weighted_completeness_percent,id,error_percent,weighted_quality_score,quality_rating,schema_version,weighted_error_percent,quality_score,title,publisher,weighted_quality_rating,completeness_percent,pid
4.76,0056a5c8-4f98-4e9e-b74a-bd498be71c0d,46.51,29.36,Not Rated,1.1.7,46.03,29.12,KPIC,,Not Rated,4.76,11dee486-22d2-4cf4-a955-512249e61645
33.33,00a784aa-ea3a-4a57-9612-81b0745e0763,51.16,41.27,Not Rated,1.1.7,50.79,33.95,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Wales,,Not Rated,19.05,602cbc9b-0113-4712-8c4a-0efe8d86b77c
33.33,00e1b694-3072-4d25-ab2d-a1de59629ae3,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),,Not Rated,19.05,24de9d1a-1f48-4c10-b8fc-a3bd7449e191
46.03,00ffee70-43d6-4a81-8568-32b0b6d9e39c,27.91,59.52,Not Rated,1.1.7,26.98,61.05,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,ALLIANCE > HQIP,Not Rated,50.0,b0979e07-3331-408f-853b-5eeba80ce8f9
60.32,0121c132-5be6-414e-853b-885ff301854f,18.6,71.43,Bronze,1.1.7,17.46,75.22,PTCL Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,19fa25a7-c15d-441c-b635-ad49043e7a96
60.32,01470238-7a17-47a5-a131-17178ba26a0a,16.28,72.22,Silver,1.1.7,15.87,76.38,Human Developmental Biology Resource (HDBR),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,399a6d67-7577-4476-a3b6-4bbceb5a8ff7
33.33,01a5c44c-c2fd-4c1e-856e-9875ee1beafa,55.81,36.5,Not Rated,1.1.7,60.32,31.62,BathTAP Switching Cohort 2,,Not Rated,19.05,ea1aca1f-6ddb-44a0-b530-0645a26b2bee
60.32,0315886c-f34a-4f1d-8f76-2dfa80a6e949,16.28,72.22,Silver,1.1.7,15.87,76.38,Cam-UroOnc Biorepository,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,21044030-1cd5-46b1-b072-c9959fd330b4
23.81,039c0b29-63f6-4ce9-8d89-87012a52e44f,32.56,45.24,Not Rated,1.1.7,33.33,48.0,The Leicester City and County Chronic Kidney Disease Cohort,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,Not Rated,28.57,4dfec37d-dd24-465f-85ea-30209aff3a26
53.97,03abf37c-41b2-4ff3-9c09-2cfea438526a,20.93,66.67,Bronze,1.1.7,20.63,70.48,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",HUB > BREATHE,Bronze,61.9,2f1244b8-7cbf-4fa3-8534-433efd769d48
33.33,03b7acd5-ecfe-4cd6-a6dc-bf9e3f98c772,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma and COPD Audit (NACAP): Adult Asthma secondary care clinical,,Not Rated,19.05,becd2624-9a01-4f01-bcf8-56e94545a49a
33.33,03cdf92e-b6ea-4e1d-a861-e9da4372ed36,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR BioResource: Consent records,,Not Rated,19.05,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c
68.25,03fb3b18-4419-44f7-a035-9ddfecfcadfc,30.23,65.87,Not Rated,1.1.7,36.51,64.64,COVIDsortium,OTHER > UNIVERSITY COLLEGE LONDON,Not Rated,59.52,529f126b-660c-4c31-aeb2-765dac1d9df0
14.29,0477b06f-cbed-4949-982e-ce248a47ed1a,37.21,38.89,Not Rated,1.1.7,36.51,39.73,SOLUS,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,e653b264-3e44-4ed1-a376-86df45db7f72
96.83,04f22c93-53df-440a-a71a-50d6827450bc,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),HUB > DISCOVER NOW,Gold,92.86,ed08c844-343e-44fa-a02d-3ad5ecf25184
33.33,04f28919-aa6c-4beb-b186-0ad0043c1c6c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Sample holding,,Not Rated,19.05,f2af20f9-af84-40ce-8a07-7d095948653e
22.22,04fb4aac-415b-4493-986b-65bbef5214d3,37.21,42.86,Not Rated,1.1.7,36.51,44.49,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,ALLIANCE > HQIP,Not Rated,26.19,1982d9ef-890a-41ff-a86a-de61d65aaa09
100.0,05716e41-9842-4c07-8ddd-af9f9231e056,13.95,92.06,Gold,1.1.7,15.87,90.64,Bowel Screening Wales,ALLIANCE > SAIL,Gold,95.24,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef
100.0,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,16.28,89.69,Gold,1.1.7,20.63,89.48,COVID-19 Shielded People list,ALLIANCE > SAIL,Gold,95.24,dc22db56-8791-4e96-9ce6-6b6a58b1241f
60.32,0664f988-276e-4268-af43-1986a3101f38,16.28,72.22,Silver,1.1.7,15.87,76.38,INCA Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,edd55990-a616-4a9c-a4a2-38af136a349b
60.32,069c213c-eb04-463e-a300-7614c03cf623,16.28,72.22,Silver,1.1.7,15.87,76.38,HCV Research UK,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,01492322-9b33-41cc-9f51-484024e45878
98.41,06dee089-8c10-4a8b-aa94-7cb699dc3c80,18.6,89.68,Gold,1.1.7,19.05,87.13,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",HUB > PIONEER,Gold,92.86,0eb789bb-0047-46ac-83ff-631f31e98da0
14.29,0711cc7e-80d5-4781-a1ab-2637ea176ceb,37.21,38.89,Not Rated,1.1.7,36.51,39.73,Millennium Clinical Events,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9
71.43,0715a950-3999-46d8-a646-6496866638a1,11.63,79.37,Silver,1.1.7,12.7,84.66,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,HUB > BREATHE,Silver,80.95,bb8de9d2-cc38-4c40-b104-ffd167f64f76
33.33,077a21b9-5c5a-4c68-a9f0-b4fa3384aead,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID-19 Sequence Data,,Not Rated,19.05,602cbc9b-0113-4712-8c4a-0efe8d86b77c
33.33,0786f8b9-77b1-4bc4-8464-28c664298adb,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Cancer Network Information System (CNIS / CANISC),,Not Rated,19.05,da91f0eb-1761-485b-8b7f-9121b6a1d004
31.75,07b82dd5-adc3-42c5-8a60-914042b5bc40,27.91,52.38,Not Rated,1.1.7,26.98,52.71,Exome sequencing,UK Biobank,Not Rated,33.33,2ddf0659-f05a-4f1c-b558-63a96e5b49f7
84.13,07e3ac82-a38d-45f3-9933-07439f6a761d,25.58,79.36,Bronze,1.1.7,25.4,75.31,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,HUB > PIONEER,Silver,76.19,323dc330-aad9-472a-b579-ab66f5f75906
33.33,084ab1d8-78f6-4c04-b829-6891c6463ca9,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Breast Test Wales (SBTW),,Not Rated,19.05,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b
88.89,08846261-45f0-4bcf-9801-fe785dcef1c9,20.93,83.34,Silver,1.1.7,22.22,80.01,Careers Wales dataset,ALLIANCE > SAIL,Silver,80.95,e4004e0e-6adb-4b11-82c2-af0caf61d751
4.76,089a0dd5-b2bd-4152-8033-d53552fe2c80,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Klang Asthma Cohort,,Not Rated,4.76,a2eddb27-c8bd-42ae-94f8-2a3026220da3
33.33,08bffe91-46aa-4718-ab3a-9e9b60353ea2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Primary Shoulder Replacement dataset,,Not Rated,19.05,0e903b9e-a329-478a-937c-480eecee4996
33.33,08d1a4f5-92b0-4142-a38d-8bac734086e8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside Pathology,,Not Rated,19.05,419e5a82-2d82-48a7-a8f3-a83e64a54e92
33.33,0910383a-44d6-4652-98da-550df7204416,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),,Not Rated,19.05,750063ea-6bfd-4492-9748-2a18080cf6ea
82.54,0942304f-8b91-4258-af9c-3a1801c7e79f,25.58,78.57,Bronze,1.1.7,25.4,74.12,The acute presentation of pregnant women to non-maternity Emergency departments,HUB > PIONEER,Silver,73.81,86632207-1e57-4272-b178-ea069a13cae1
4.76,0969dc51-1ab9-469a-8b35-3ec63f30fa89,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme - National Heart Failure Audit,,Not Rated,4.76,834618f3-0c6d-4ed2-abae-39208c6b3080
60.32,097cc6bd-ce98-47ec-a73d-5d2c250f2697,16.28,72.22,Silver,1.1.7,15.87,76.38,ICON9 Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,1fdf266c-d5d8-418d-a423-81265da540a2
33.33,09d1cc0f-4b4d-4525-853a-012ece4a1ab2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Revision Hip Replacement dataset,,Not Rated,19.05,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de
4.76,09f04291-670d-4db0-a3e4-7e0d84555231,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Development of ELISA and Rapid Testing Kits for COVID-19,,Not Rated,4.76,6b2aca2c-b03a-44ba-80a1-883b744421b6
4.76,0a137eec-4288-400b-8c47-0275319c9f09,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Lothian Birth Cohort 1921 (LBC1921),,Not Rated,4.76,df288318-6663-417d-9870-666e75920bed
100.0,0abfceb7-5a56-4559-b0d4-88326e0331a3,16.28,89.69,Gold,1.1.7,20.63,89.48,Pathology Data from WRRS,ALLIANCE > SAIL,Gold,95.24,48ef8f54-9606-4e6f-9256-3cc07ffd10b8
33.33,0ac16d3d-5ca8-4e25-ad46-ce8e03a04e17,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Pathology Data from WRRS (PATH) - Legacy,,Not Rated,19.05,48ef8f54-9606-4e6f-9256-3cc07ffd10b8
85.71,0ac9438e-da8d-4488-bdc6-8285d1401b1d,25.58,78.57,Silver,1.1.7,28.57,76.5,Census 2011 E&W - Household structure for COVID-19 models,NCS > OFFICE FOR NATIONAL STATISTICS,Silver,78.57,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8
4.76,0b06a5c0-f015-4ce6-bf53-cab304334ae0,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Determinants of Adolescent Social Wellbeing & Health (DASH),,Not Rated,4.76,9d242d12-2d2e-4941-93e4-9ec40d239dd1
60.32,0b7ea326-fc05-4aca-a962-3f93128b91d1,18.6,70.64,Bronze,1.1.7,19.05,75.22,HPB Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,ebe6c9dd-fb95-4301-a929-c21b8077753a
33.33,0b835c3e-9968-4f12-8aad-c4f10a7d460f,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Demographic Service Dataset (WDSD),,Not Rated,19.05,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d
57.14,0c219a61-a1d6-4c5b-bec2-3537454e4137,18.6,69.05,Bronze,1.1.7,19.05,74.03,Teleconsultation in remote rural India: management of COPD and Asthma,HUB > BREATHE,Bronze,66.67,de496590-26b3-4e74-bc5e-1ff5c83f5b43
60.32,0c50801d-1079-4879-b608-5e8f112b313f,18.6,70.64,Bronze,1.1.7,19.05,75.22,Tissue Access for Patient Benefit (TAPb),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,35985f8e-f01a-41cc-a9e2-30299d3d6eed
58.73,0c78d1cf-4ba6-44f4-adcf-16c15142d8fb,16.28,69.84,Silver,1.1.7,19.05,77.58,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),HUB > BREATHE,Bronze,71.43,25bc9862-5b6c-4dda-80b2-46642d9e518a
33.33,0c8fcf41-177b-4ca8-a01f-d86ca8bd5a03,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Substance Misuse Dataset (SMDS),,Not Rated,19.05,291c0dd4-0988-42d2-8e0b-878a892add57
46.03,0c98200b-48b5-418a-b8d0-a7708abc1f39,32.56,57.94,Not Rated,1.1.7,30.16,57.53,Mental Health Services Data Set - Community,ALLIANCE > NHS DIGITAL,Not Rated,47.62,f3bb6a68-2c32-40a7-9a79-61a718068893
33.33,0cd32bab-357b-4ea2-bba0-eca90b7b36e9,55.81,36.5,Not Rated,1.1.7,60.32,31.62,"Problem, Diagnosis and Procedures",,Not Rated,19.05,51b41359-1558-48df-9950-88f75ca6ac4c
4.76,0d65fabc-6cb0-4a77-a01d-cb341b0b053c,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR IBD BioResource: NHS Trust data,,Not Rated,4.76,ae1898da-7fe5-4fe0-b10d-9f06cdec1735
63.49,0d6ab9af-c43b-490d-b39c-2d72de46a661,16.28,73.81,Silver,1.1.7,15.87,77.58,The Cleft Collective,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,12288034-00a4-47a8-a779-1cf7a55270e4
60.32,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,16.28,72.22,Silver,1.1.7,15.87,76.38,MRC Brain Banks Network,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211
60.32,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,16.28,72.22,Silver,1.1.7,15.87,76.38,Leeds NIHR Biomarker Research Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,8648d251-6186-4383-82fc-c036a87c3842
33.33,0ddb1d67-e0b9-4b08-898c-9957a09d7e69,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Renal Register – PHS National Dataset,,Not Rated,19.05,32edd77d-533c-423f-b045-937507f8505d
79.37,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,32.56,73.02,Bronze,1.1.7,33.33,70.62,Real Time Data Network (RTDN),HUB > DATA-CAN,Bronze,73.81,616c4488-65a5-4608-a187-0c6bc78b359a
79.37,0e07413c-892c-4f06-bd22-2a917eb5c905,27.91,74.61,Bronze,1.1.7,30.16,71.76,Cancer Registration Data,ALLIANCE > NHS DIGITAL,Bronze,71.43,2ed7bbbc-80db-46c2-a45b-632dda40794b
77.78,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,64.29,29c61f09-c4a1-425f-9bbc-888c23d99516
33.33,0e9e034a-913a-4764-8615-961c3647b268,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Cancer and cerebrovascular events: frequency, cancer types and outcomes",,Not Rated,19.05,ae3fd121-141d-466b-b002-06c3959116d0
60.32,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,16.28,72.22,Silver,1.1.7,15.87,76.38,Cardamon Clinical Trial Samples,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1
33.33,0efcd6ce-4e7a-4f8e-8903-1a987ec76b1c,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Better Rx BRIT2 Patient GP Dataset,,Not Rated,19.05,656b2c22-9e57-4f15-9b3c-1969da6495ca
4.76,0f1a2789-e8b3-4e36-9622-65d76cebff26,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme -  Congenital Heart Disease Audit (NCHDA),,Not Rated,4.76,2b640175-725a-465f-9aec-6794e6d27791
60.32,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,16.28,72.22,Silver,1.1.7,15.87,76.38,UKALL14 Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,b5533cb5-0c59-495b-9b11-3c401daeb958
77.78,0fc61ace-397d-4489-9e62-77f88082e775,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,9c8bd383-b117-4167-a25c-9e15fa5ec1c6
4.76,1045ca85-0c8f-453b-9da3-778144cf3744,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"National Audit of Dementia - spotlight audit on  psychotropic medication, 2019",,Not Rated,4.76,949d9d7a-a3f1-480a-8563-3fb024300561
33.33,1046cc4d-bd35-43de-a156-80bddb3eb415,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 Test Trace and Protect (CTTP),,Not Rated,19.05,c0fc84af-aeab-4c7e-aa0b-8264baff55d9
33.33,108d652d-3afb-4001-8ae6-b5a42e8b2daa,51.16,41.27,Not Rated,1.1.7,50.79,33.95,NHS 111 Dataset (NHSO),,Not Rated,19.05,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf
4.76,112db000-f69f-47a4-8dd7-db7b6d839e68,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Bangladesh Asthma Hajj Study,,Not Rated,4.76,27e1ffc7-5804-40e2-83e2-93f570906127
33.33,115109e7-9a35-420f-831e-0707bc96375c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK SARS-CoV-2 viral sequencing data (COG-UK) - Lineage/Variant Data - NI,,Not Rated,19.05,3d2d9c5e-6111-4583-a6db-07affd628f1e
23.81,1199f5b5-99f0-4aae-9769-ab754f05dcdb,32.56,45.24,Not Rated,1.1.7,33.33,48.0,National Maternity and Perinatal Audit Organisational Survey 2019,ALLIANCE > HQIP,Not Rated,28.57,01ad25ed-8cde-43d7-bc77-d8cc3d165df4
33.33,125202ff-1d00-4f8e-96e1-1d5a310ab326,51.16,41.27,Not Rated,1.1.7,50.79,33.95,2019 UK Parkinson's Audit - Occupational therapy,,Not Rated,19.05,9890eee9-44d4-49f7-8674-16c05a5f82e0
4.76,12d62b02-2167-407d-acdb-6ddb9d251d36,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR IBD BioResource: SNP imputation data,,Not Rated,4.76,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2
60.32,12dba445-dfa9-46af-abc0-5bd3701061a7,18.6,71.43,Bronze,1.1.7,17.46,75.22,UK primary Sjogren's syndrome Registry,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5
33.33,135f2650-ea0c-4cad-80ac-c86449a176a8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside Radiology,,Not Rated,19.05,af10ec29-1866-4726-b33f-3948afe182f2
60.32,1406c52a-e5d6-4c57-883d-62e405eb604a,18.6,71.43,Bronze,1.1.7,17.46,75.22,Manchester Eye Tissue Repository,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,47fc8f03-eba1-4efa-ae3e-148a76b56517
33.33,140ce7b6-8a58-4d0f-a24b-81b0f4289a68,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Referral to Treatment Times (RTTD),,Not Rated,19.05,0bf54842-c1db-4bdb-9f55-c5be490bf758
50.79,1450ff1a-4526-4a6e-b9e9-25969878449d,20.93,64.28,Bronze,1.1.7,22.22,70.48,COPDMAP Consortium,HUB > BREATHE,Not Rated,61.9,bcbc41cb-99f7-482e-ba3d-561164abbd4e
46.03,145916c8-d3ca-4465-a719-93dd0770a6e4,16.28,64.28,Bronze,1.1.7,17.46,69.24,Optimum Patient Care Research Database,HUB > BREATHE,Not Rated,54.76,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088
33.33,147576e2-b445-4d36-aecc-d604302bd34e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma and COPD Audit  (NACAP): secondary care  – CYP asthma (org),,Not Rated,19.05,3efd9b30-1f84-48c0-a3e0-402ecb5c7724
100.0,148ebbaa-28f4-42e0-a27f-8587e516c3bf,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Sweat Tests,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,34f0c2bd-d42e-4441-a89b-e0e384f12afa
100.0,15805559-2115-4822-b91f-635de36fb289,16.28,89.69,Gold,1.1.7,20.63,89.48,Active Adult Survey,ALLIANCE > SAIL,Gold,95.24,1eb67fd5-33f6-49dd-a43d-854fff9f25f5
88.89,1584af1e-9683-4727-8c9b-9bea8beaa68d,25.58,80.16,Silver,1.1.7,28.57,77.69,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,HUB > PIONEER,Silver,80.95,5bf9bf39-3cd7-4a54-994b-9914405f945e
4.76,15aebc30-1e52-4a36-8b17-f9801f35f649,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Health and Employment After Fifty (HEAF),,Not Rated,4.76,ea2d54a2-a6d4-4e82-b2e4-95184f00bbdc
100.0,15efea36-d022-495c-a5b6-90f51631a643,18.6,90.47,Gold,1.1.7,19.05,88.32,GENOMICS ENGLAND 100K QUICK VIEW,GENOMICS ENGLAND,Gold,95.24,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c
88.89,1638cce2-12f5-410b-9624-86d2f407c502,20.93,80.95,Silver,1.1.7,26.98,81.2,COVID-19 Clinical Information Network (CO-CIN),ALLIANCE > ISARIC 4C,Silver,83.33,84336be3-23bd-466e-b29b-df48db897665
63.49,16445ebd-bd45-4ded-a7ae-05f33f676598,16.28,73.81,Silver,1.1.7,15.87,77.58,MFT Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,d17efe5d-325f-4fcf-b25e-87d1f6269bea
60.32,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,16.28,72.22,Silver,1.1.7,15.87,76.38,Cambridge Blood and Stem Cell Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,c51ab59a-33ce-4145-a642-7f3f96bca545
33.33,16d40748-66f1-4fc3-bdb3-7c8103cadeb7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,2019 UK Parkinson's Audit - Physiotherapy,,Not Rated,19.05,27690c58-a5da-4359-909a-8e19ff6ca463
33.33,16f11980-e2e7-4f79-8e33-39ba4dc3547f,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Suspected Cancer Pathway Daily (SPCD),,Not Rated,19.05,9ea2f685-d6c2-49fe-a0e2-735910584d67
14.29,172242ce-a1c5-4915-9c71-686f6e7d5789,37.21,38.89,Not Rated,1.1.7,36.51,39.73,ARIA Medonc,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,88eb839c-bc51-45f0-b15e-ea89bba9ffca
88.89,1785cc1a-ace0-4980-8352-5977b2b72969,25.58,80.16,Silver,1.1.7,28.57,77.69,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,HUB > PIONEER,Silver,80.95,5acfadf9-21a7-4517-a1b2-620d20469611
60.32,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,18.6,71.43,Bronze,1.1.7,17.46,75.22,IoN Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,e10a660d-b84c-475f-abd4-024dd1af7a5d
100.0,1900af1a-bd21-4157-ac48-203eec682073,16.28,89.69,Gold,1.1.7,20.63,89.48,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,ALLIANCE > GENOMICS ENGLAND,Gold,95.24,98999c67-0133-4f11-be95-b84ee5727c84
4.76,19231ac4-4256-46e5-958b-b98d12e036f8,46.51,29.36,Not Rated,1.1.7,46.03,29.12,UK Biobank - Online Questionnaires,,Not Rated,4.76,70dc8c5d-2dfa-429d-bfd3-695f5904c244
33.33,19525c5f-92ee-41b6-bb79-673624b27bdd,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Improving Access to Psychological Therapies Data Set,,Not Rated,19.05,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd
33.33,196dc924-9289-4f31-900d-d9310dc34361,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Patient Episode Dataset for Wales (PEDW),,Not Rated,19.05,4c33a5d2-164c-41d7-9797-dc2b008cc852
33.33,199b8c9f-baf2-4eb8-a8fe-783f58eceb2e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 Consolidated Deaths (CDDS),,Not Rated,19.05,70e37f44-5c3e-4c83-a42a-89b3476d1d45
63.49,1a412ff0-6275-4cab-a485-bb76befc7afe,16.28,73.81,Silver,1.1.7,15.87,77.58,UK real-world lymphoid tissue bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,c9f82f86-79e1-4067-932f-5e6dc939006d
100.0,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient CFQ-R,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f
33.33,1bafa55c-5616-47db-8ac8-798038146254,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",,Not Rated,19.05,36886b21-12ff-45e7-82bc-fb5308c12450
23.81,1bbcb128-dd3e-4f56-81d5-17df2dab3c52,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,ALLIANCE > HQIP,Not Rated,28.57,4559a14f-563d-4fd2-93ae-27c6c0fd891e
90.48,1bc9ccd6-44d0-43db-843a-f9fa293c4090,30.23,79.37,Bronze,1.1.7,31.75,75.36,Mother-Baby Link for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,b734a1b5-37d3-4859-85d4-bf011df2a951
85.71,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,23.26,80.95,Silver,1.1.7,23.81,77.66,NIHR BioResource: Health and Lifestyle Questionnaire,ALLIANCE > NIHR BIORESOURCE,Silver,78.57,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5
33.33,1c524f7c-ee22-4bdc-877b-8dddc03e3aa2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Deaths General Registrar Office – National Records Scotland,,Not Rated,19.05,5362cfea-d554-43ba-916a-4460da39cc0c
92.06,1c942123-845d-4c31-9f04-8e044be00e58,30.23,80.16,Silver,1.1.7,31.75,77.74,HES Admitted Patient Care data for CPRD Aurum,ALLIANCE > CPRD,Silver,85.71,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee
4.76,1ca52b96-27d9-491a-b5f0-5787852d39d2,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Sero-surveillance to monitor the trend of SARS-CoV-2 infection in rural India,,Not Rated,4.76,185e9c5c-e686-4174-bcba-5e2f584b5cbb
46.03,1cb397d5-a86d-4354-b1f7-565b7ef5054b,23.26,61.11,Not Rated,1.1.7,23.81,65.75,Asthma self-management behaviour in Bangladesh and Pakistan,HUB > BREATHE,Not Rated,54.76,3b378225-48e1-45fa-b62d-fc4ed4b39bec
33.33,1cc3dc2c-adf3-4c66-ab7b-cfc00388a6a8,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Labour Force Survey (Person),,Not Rated,19.05,8c60a308-1e47-4a0c-8b69-9259f05338cb
33.33,1d2acc70-0e2d-4601-bbbb-569a49bfaa5b,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside Microbiology: Tests,,Not Rated,19.05,826be5be-9977-49f9-b6d1-83ed9de08ebe
100.0,1d46f920-e253-4e7d-a72a-843d068d3c69,16.28,89.69,Gold,1.1.7,20.63,89.48,Critical Care Dataset,ALLIANCE > SAIL,Gold,95.24,1789286a-deaf-49df-88cd-660e92934af6
46.03,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,32.56,57.94,Not Rated,1.1.7,30.16,57.53,Mental Health Services Data Set - Service Users,ALLIANCE > NHS DIGITAL,Not Rated,47.62,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a
15.87,1e465797-5e54-4667-9120-d373e75be64f,39.53,38.88,Not Rated,1.1.7,38.1,39.76,Somerset Cancer Registry,ALLIANCE > BARTS HEALTH,Not Rated,19.05,3ec5f1c4-95c0-4b1d-899b-399cec32ad49
33.33,1e875c15-4a99-4c3e-9621-e4ebf594469f,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK Renal Registry - CKD and AKI on Dialysis Dataset,,Not Rated,19.05,b7152f21-0f2c-4ed9-a013-51e725242f94
33.33,1f6118ce-4051-4ba6-b13e-63dca0032d8d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Emergency Care Data Set (ECDS),,Not Rated,19.05,7749d90e-dd7a-4697-8a9c-666491c64a0c
33.33,1fd6e7d5-266a-4c79-b492-7045910cd291,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 Shielded People List (CVSP),,Not Rated,19.05,dc22db56-8791-4e96-9ce6-6b6a58b1241f
23.81,203cc8b4-7711-4d1f-9213-af982d6cff28,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Sentinel Stroke National Audit Programme Clinical Dataset,ALLIANCE > HQIP,Not Rated,28.57,059a6495-a7d5-435b-8e2b-806c6ccccf2e
96.83,208f79dc-2294-4370-8f16-0d0f7bec9d10,20.93,86.51,Silver,1.1.7,23.81,85.97,Moorfields Eye Image Dataset Release 001,HUB > INSIGHT,Gold,92.86,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc
71.43,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,32.56,69.84,Bronze,1.1.7,31.75,74.19,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,ALLIANCE > SLaM,Bronze,80.95,a25a9892-9141-4e78-8415-945ba73da11e
4.76,21d1277b-baf8-4fb8-826e-3f4910d18098,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR BioResource: Returned datasets,,Not Rated,4.76,261bcf76-8621-4f0d-b2e6-310993d73daa
85.71,22173802-db99-475e-b95e-d69798734077,25.58,77.78,Silver,1.1.7,30.16,76.5,NHS 111 Dataset,ALLIANCE > SAIL,Silver,78.57,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf
33.33,226b52f4-1be8-46c2-86a4-261eb48ec542,51.16,41.27,Not Rated,1.1.7,50.79,33.95,SAIL Dementia e-Cohort (SDEC),,Not Rated,19.05,f48b7c05-6a44-480c-84c6-4f7a684f29f8
63.49,22739526-317f-4b0e-a23b-ece0c859958f,16.28,73.81,Silver,1.1.7,15.87,77.58,QTL Programme at MRC HGU,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,351cc017-caff-4303-8a48-1aa1b90fce2b
60.32,227fe0ea-d76e-4c14-a33e-ca255380937d,16.28,72.22,Silver,1.1.7,15.87,76.38,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,c232fa07-5d28-4bdc-b540-1ad8d933c5f9
60.32,22974866-44c7-4176-9c51-6b57a1dda39d,16.28,72.22,Silver,1.1.7,15.87,76.38,University of Liverpool - GCP Laboratory Facility,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,029b7f0f-911e-46ce-837f-031959f067da
19.05,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,39.53,40.48,Not Rated,1.1.7,38.1,40.95,CDE Encounters,ALLIANCE > BARTS HEALTH,Not Rated,21.43,3598723f-62fb-4377-9a8b-b264ced1aabd
100.0,239e8253-a997-4676-8940-16b74a004365,23.26,85.72,Silver,1.1.7,28.57,85.99,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,GENOMICS ENGLAND,Silver,95.24,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d
33.33,23d790f2-de80-4c7a-b57a-03c8467c54e9,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Accident & Emergency Dataset (PHS/National),,Not Rated,19.05,750063ea-6bfd-4492-9748-2a18080cf6ea
60.32,24f2374a-e804-434e-a805-e29b332b0693,18.6,71.43,Bronze,1.1.7,17.46,75.22,SWIFT-RTB,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,d387ed7c-14fa-49e2-8ced-df0f9372eb88
90.48,2550f814-0849-4d19-b83e-edef46b157fb,23.26,81.75,Silver,1.1.7,26.98,80.03,Intensive Care National Audit and Research Centre - Covid19,ALLIANCE > SAIL,Silver,83.33,add6226b-0f21-439a-84a6-51dc26cdc425
33.33,260f4fb2-b40a-4e20-888d-1e3c9c2ddd8e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,DOLORISK,,Not Rated,19.05,0a467180-a898-44d8-a586-ca4762de362e
87.3,262c28eb-151e-4ab2-a813-81841f5292eb,27.91,80.16,Bronze,1.1.7,26.98,75.33,Patient postcode linked deprivation measures for CPRD Aurum,ALLIANCE > CPRD,Silver,78.57,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a
77.78,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,64.29,2964d1b0-2630-468a-82c1-00f5ac901b3d
77.78,263f28a4-9835-4856-b1c3-0a0d4085f207,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v2.6 (Sensitive),ALLIANCE > NHS DIGITAL,Not Rated,64.29,dc37fcd6-1e68-46e5-b73d-4896e069746a
65.08,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,16.28,74.6,Silver,1.1.7,15.87,78.77,Arden Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,73.81,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b
33.33,268d54cf-189e-46ea-8f0e-71ad8907bea3,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Dispensing Dataset (WDDS),,Not Rated,19.05,50ef6443-ed4b-40f9-97fb-1cfd53be6579
33.33,26ac9d75-df76-49e5-ba41-d4c0e83a8765,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Child Health Systems Programme - 27-30Months Review,,Not Rated,19.05,d2d57b7f-95d8-425f-b2fd-cc9aff05e659
66.67,270b55a8-a9ee-44ee-8db6-eb214e721eea,18.6,74.6,Silver,1.1.7,17.46,78.8,Scottish Human Papillomavirus Archive,ALLIANCE > TISSUE DIRECTORY,Bronze,76.19,4883530f-1c8d-49aa-886e-ea3b958772ea
85.71,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,25.58,80.16,Silver,1.1.7,25.4,76.5,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",HUB > PIONEER,Silver,78.57,38ff49e2-dffa-4103-87a8-386f9f424d22
30.16,274238a8-ec06-4ee4-83ae-a419a925d43b,27.91,50.8,Not Rated,1.1.7,28.57,53.9,Unified Cohorts Research Network,HUB > BREATHE,Not Rated,35.71,cffcf30d-cedb-421b-a5dc-6726633cb99a
33.33,27a97f1b-e7ac-4723-87db-0a4d9e3ed4b6,55.81,36.5,Not Rated,1.1.7,60.32,31.62,NIHR IBD BioResource: SNP chip data,,Not Rated,19.05,3c749cfc-4008-4916-b64f-969d6a754c0f
33.33,2887c7b4-66d4-404c-a352-83fcff441568,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Cholecystectomy and post-operative complications from over 9000 surgical cases,,Not Rated,19.05,4abba8ec-9a67-4334-91fc-e624173f3055
88.89,2918676c-74b0-4a4e-8814-697e9aa6a81c,30.23,80.16,Bronze,1.1.7,28.57,75.36,National Radiotherapy Dataset (RTDS) for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,56a66de8-3470-4a36-ac71-4d5471e72654
15.87,29de7178-dcf3-4859-bd96-ca6d944db5f8,41.86,38.09,Not Rated,1.1.7,39.68,38.59,DENDRITE Dataset,ALLIANCE > BARTS HEALTH,Not Rated,19.05,31920b14-d114-410f-8255-522e6451c44e
4.76,2a17a802-a2da-4bfc-8571-b2015350eed4,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Treatment of Bangladeshi children with severe pneumonia,,Not Rated,4.76,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b
33.33,2a4ef602-0485-47d2-a6f7-9e2ccf849a5d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Audit of Care at the End of Life - Quality Survey,,Not Rated,19.05,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2
77.78,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,7c2b435c-5442-4a05-9b8d-08024ec57c30
33.33,2a826781-0f58-44d6-89f3-7d899eb3cd45,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma and COPD Audit (NACAP): COPD secondary care clinical dataset,,Not Rated,19.05,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6
98.41,2b09ea87-5b22-4049-b7dd-de0889699115,18.6,88.09,Gold,1.1.7,22.22,87.13,Millennium Cohort Study,ALLIANCE > SAIL,Gold,92.86,a380bd6b-009f-4b78-b638-ba9ee62be2eb
85.71,2b40a784-79ea-4403-a4bd-0950a7a36a6c,27.91,79.36,Bronze,1.1.7,26.98,75.33,Leeds-IQVIA Collaboration,HUB > DATA-CAN,Silver,78.57,00b897c7-d50d-486a-af1b-bd94821b58f7
33.33,2b77663f-c71d-4138-8fad-f45a1f8b1222,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),,Not Rated,19.05,d47c809f-3da8-4f8a-b1ee-258d21aad530
63.49,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,20.93,71.43,Bronze,1.1.7,20.63,75.25,UCL Infection DNA Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,3e5fb54a-84ec-4888-9a72-4093c6e90dbc
60.32,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,16.28,72.22,Silver,1.1.7,15.87,76.38,MDSBio,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,13c71637-144e-4742-8aea-aefb778a360e
33.33,2ca2a23d-64c3-4691-9289-197436dddfa3,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Millennium Cohort Study Dataset (MCSD),,Not Rated,19.05,a380bd6b-009f-4b78-b638-ba9ee62be2eb
33.33,2cb07157-1c99-48dc-9926-0ad968a09166,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Higher Education Statistics Agency (HESA) Student Data,,Not Rated,19.05,68b04d3b-17b4-4a04-a8a3-e2a93ed231df
88.89,2d25b733-d95a-485b-9499-907a48b51919,32.56,76.19,Bronze,1.1.7,36.51,74.19,Mental Health Dataset (MHDS) for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,d5c0cc93-3347-46f0-b8dd-f44e82718e38
100.0,2d4b933d-1c8b-4fde-860e-c324454d28f9,20.93,88.09,Gold,1.1.7,23.81,87.16,GENOMICS ENGLAND 100K NHSD LINKED DATA,GENOMICS ENGLAND,Gold,95.24,14c31b39-f189-4417-bd38-635268495593
33.33,2d4d0d89-edfb-448a-b95b-a3c0401ebe75,55.81,36.5,Not Rated,1.1.7,60.32,31.62,COVID-19 Vaccination Adverse Reaction,,Not Rated,19.05,080a90e4-4bc6-4153-a4c6-c120eef5ba94
47.62,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,20.93,62.7,Bronze,1.1.7,22.22,68.1,IBD NIHR BioResource: NHS Trust data,HUB > GUT REACTION,Not Rated,57.14,ae1898da-7fe5-4fe0-b10d-9f06cdec1735
33.33,2d7a047c-a90f-48e4-82ee-9a8a082a696e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Cancer Intelligence and Surveillance Unit (WCISU),,Not Rated,19.05,368ad790-3ad8-4f93-9a7c-0bfb64dc6015
33.33,2d9240b4-6f54-4d00-9c2e-d19220c33211,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside - A&E drugs given during an A&E visit,,Not Rated,19.05,acfbef89-344c-49a5-8079-7344f4316e0f
33.33,2e98ae87-b10d-4aa0-acec-773a2b028af1,53.49,38.88,Not Rated,1.1.7,55.56,32.78,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - NI,,Not Rated,19.05,3d2d9c5e-6111-4583-a6db-07affd628f1e
100.0,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,16.28,91.27,Gold,1.1.7,17.46,89.48,Patient Episode Dataset for Wales,ALLIANCE > SAIL,Gold,95.24,4c33a5d2-164c-41d7-9797-dc2b008cc852
4.76,2f9c0340-2116-41f5-bdbd-921561476061,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Community perception on public health measures for COVID-19 prevention/control,,Not Rated,4.76,6464fb4f-2838-495b-9963-4001204ed166
33.33,2fcd3d4f-773b-4adc-a8cf-c80841c92d51,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Deaths – National Records Scotland,,Not Rated,19.05,5362cfea-d554-43ba-916a-4460da39cc0c
60.32,2fee4aae-94c4-40b2-9e35-4f9558a5b223,20.93,69.84,Bronze,1.1.7,20.63,72.87,Cancer Patient Experience Survey (CPES) for CPRD Aurum,ALLIANCE > CPRD,Bronze,66.67,fded6e24-8fef-47a4-a65e-9455bed043d3
33.33,3008933e-6fc1-415c-b2c6-ebb12e8f3b99,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CDE Patient Demographics,,Not Rated,19.05,209d7fae-0521-4d07-8a4d-e0843a46a107
33.33,30524e8c-c92c-4f01-84bd-c5593ada3e43,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Covid-19 UK Non-hospital Antigen Testing Results,,Not Rated,19.05,f06ec631-77d0-4b12-a21f-f11e7af49ba5
60.32,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,16.28,72.22,Silver,1.1.7,15.87,76.38,Watch and Wait Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,e46dccbf-484d-45d2-a42a-4d308b87c113
33.33,30e1343e-0628-47aa-b4f6-756cdb6e54c6,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID-19 Sequence Data (CVSD),,Not Rated,19.05,602cbc9b-0113-4712-8c4a-0efe8d86b77c
33.33,31503f67-c546-4223-aec6-9255263e8b66,51.16,41.27,Not Rated,1.1.7,50.79,33.95,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),,Not Rated,19.05,98cda353-0011-45b2-80ca-4ed24cd084bf
4.76,320d4c1e-df08-4eaa-ab9f-bd342d1799a0,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Webex Cohort,,Not Rated,4.76,9254f941-db57-4a97-922e-880b84855a21
85.71,32bff357-1c24-43d5-8741-261f5a764802,30.23,78.57,Bronze,1.1.7,28.57,72.98,Practice postcode linked deprivation measures for CPRD Aurum,ALLIANCE > CPRD,Silver,76.19,9f689ef4-26c6-4f85-80ff-5116974f315a
33.33,32f2d582-3b99-44a8-ac30-0a0819fc2523,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Falls and Fragility Fracture Audit  National Hip Fracture clinical dataset,,Not Rated,19.05,e06b951b-e9d8-4a2c-a51f-1d819f669205
100.0,333d92ca-3a32-41bd-8b16-96aee2dc85b1,18.6,88.89,Gold,1.1.7,22.22,88.32,Wales Asthma Observatory,HUB > BREATHE,Gold,95.24,8604bcdc-235a-4c70-b29b-1617396815e6
4.76,3373aa9c-219e-4036-91a5-78bb98e8a7f5,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Bowel Cancer Audit -  Organisational Survey dataset,,Not Rated,4.76,4e232aa8-ad56-4d82-adcc-cd06715a5c45
60.32,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,18.6,71.43,Bronze,1.1.7,17.46,75.22,TRICON8B,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,ff875c08-58e6-4e33-8ffe-6f51c8364333
33.33,34396fa9-0691-42a6-9477-e49e3ae854e6,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Neonatal Research Database,,Not Rated,19.05,67020745-9def-4c6e-b5ac-bb273bd0a20e
33.33,349f5326-67b5-4ff8-a9b8-8e6c4e42a9f2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Emergency Department (eEMS),,Not Rated,19.05,2ba72371-1527-4d8d-94e2-f795e45b9f77
33.33,34c47ecf-09ff-4f12-afaa-50c785d482c5,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Rural Payments Wales (RPWD),,Not Rated,19.05,9dc76035-dd6c-4246-8686-403087ed8890
85.71,34d2310f-c5f2-42c4-be1a-31c1ad579013,27.91,78.57,Bronze,1.1.7,28.57,75.33,Hospital Episode Statistics Critical Care,ALLIANCE > NHS DIGITAL,Silver,78.57,80564a6b-1458-41de-a131-772eb93c0509
85.71,34f9be53-2445-439b-8ca4-f151359d7e46,27.91,79.36,Bronze,1.1.7,26.98,75.33,National Cancer TRE,HUB > DATA-CAN,Silver,78.57,b5439bc5-8141-4a13-a024-a6db2003b40e
33.33,3587e2f5-1cf5-4dd3-82ed-c36be7eab130,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Welsh Ambulance Services NHS Trust (WASD),,Not Rated,19.05,4dd97609-2753-46ed-8066-3482d6dbdb34
63.49,359006d7-1c6c-43c2-8905-09b016398ae1,16.28,73.81,Silver,1.1.7,15.87,77.58,BRAIN UK,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4
4.76,3591992f-cfae-4e26-96e7-da80997e81e7,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Audit of Dementia Round 4 - organisational checklist,,Not Rated,4.76,0a305b29-cf23-4261-9299-5251e41ee9f0
33.33,35919e8c-5cea-4d79-bf3f-e28efec1b686,51.16,41.27,Not Rated,1.1.7,50.79,33.95,NIHR BioResource: Full Blood Counts,,Not Rated,19.05,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5
33.33,35cc06b0-3de1-45b0-8d40-9a8da9b77866,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Virology,,Not Rated,19.05,855a84b2-9d58-4b2b-a450-b6c6d534e403
4.76,35fde6f6-ff7d-44f0-92fc-1d28b488cbc1,46.51,29.36,Not Rated,1.1.7,46.03,29.12,The Malaysian Asthma Hajj Study,,Not Rated,4.76,8187f77f-65e3-435e-ad7e-d7f22e2fcf80
77.78,36047c5f-7d57-4d25-a114-2bcc6c11708f,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v3_3.5 (Sensitive),ALLIANCE > NHS DIGITAL,Not Rated,64.29,c123f74c-0731-428e-b31b-eee2723df54d
85.71,36d3480e-38ae-470c-ab6f-b704ee2645ec,30.23,78.57,Bronze,1.1.7,28.57,72.98,Practice postcode linked deprivation measures for CPRD GOLD,ALLIANCE > CPRD,Silver,76.19,3326d554-ca11-4dc6-aff0-c5b314442d27
47.62,36e6b617-ecd5-4ae2-87d6-4a00bb2c653a,20.93,63.5,Bronze,1.1.7,20.63,66.91,Exploring the provision of supportive care for patients with COPD in Malaysia,HUB > BREATHE,Not Rated,54.76,af8cdc87-789e-4bea-9d8b-927aa689d211
88.89,372083bc-3243-4fce-989d-914e677a12cd,30.23,80.16,Bronze,1.1.7,28.57,75.36,National Radiotherapy Dataset (RTDS) for CPRD Aurum,ALLIANCE > CPRD,Silver,80.95,9c535c8d-ebac-4212-b602-fc2489df2c92
33.33,375dae92-2015-478b-b1bc-5de90b6d53a9,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Glaucoma dataset at University Hospitals Birmingham,,Not Rated,19.05,48c44534-0184-471e-93b8-1385f92c6631
63.49,37687806-bab2-4de8-87a7-844a0061e7f8,16.28,73.81,Silver,1.1.7,15.87,77.58,Bristol Dental School Saliva Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,8d77f0ad-f376-4d61-a97d-5e996c2bbe72
63.49,381413fe-8808-47f8-b8df-e65baa543ae4,16.28,73.81,Silver,1.1.7,15.87,77.58,UK MND Collections,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,89e2d798-c488-4eaf-a50f-a93616093304
96.83,38194ca7-57f5-40ff-b463-900e306cd40f,20.93,84.92,Silver,1.1.7,26.98,85.97,North West London Pathology (NWL PATH),HUB > DISCOVER NOW,Silver,92.86,2c5f3ef6-53f8-42e6-a077-8718261df026
60.32,38254214-35f1-4564-b7bb-aab331732dab,18.6,70.64,Bronze,1.1.7,19.05,75.22,NIHR Nottingham Digestive Diseases Collection,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,f20bf814-ee80-4e67-ab00-afff884ddbb4
33.33,382d8665-a580-4ac1-a279-4fa53cb5bcc1,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Admitted Patient Care Dataset,,Not Rated,19.05,b67f0edd-fed2-4d68-a25f-d225759aa3b0
100.0,38468759-3351-4722-9eeb-4c6dc9fa44ce,13.95,92.06,Gold,1.1.7,15.87,90.64,Congenital Anomaly Register and Information Service,ALLIANCE > SAIL,Gold,95.24,6fe7e004-eb51-4c7b-9905-1ec9a4827dca
33.33,38b0da08-c889-4538-95f2-f2f2c1a86919,51.16,41.27,Not Rated,1.1.7,50.79,33.95,National Exercise Referral Scheme (NERS),,Not Rated,19.05,131784c0-769d-4f7b-b7d0-b5f4b89886d4
85.71,391ab58c-3412-4fa0-96f6-fdd5ae380b86,25.58,80.16,Silver,1.1.7,25.4,76.5,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,HUB > PIONEER,Silver,78.57,a9018475-452b-4864-bbc3-80eda2067820
77.78,3935e2fd-0c30-4f56-8388-45a02e0499b4,39.53,67.46,Not Rated,1.1.7,42.86,62.38,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,ALLIANCE > NHS DIGITAL,Bronze,64.29,2f73575d-23c8-4bb8-87db-115cde076127
4.76,39445f3f-c05c-4967-81a9-77a34529ad8e,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Optimising the treatment of Bangladeshi adults with severe pneumonia or ARDS,,Not Rated,4.76,224b1065-340b-4c01-842f-d422911d9334
4.76,396e55fb-9a71-4b8c-9e33-2e7179a87d1f,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Neuropathic Pain Profiling in Retroviral Infection Study (NIPPR),,Not Rated,4.76,41f5c96c-a27a-4015-be50-af967b6c4bac
4.76,3a0a0acd-c549-41f4-8188-14235decf473,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"BRIAN App - Patient data; treatments, PROMs, multi-modal data and demographics",,Not Rated,4.76,37c82bb7-eaae-4f16-97b6-045373b7ba18
33.33,3a0d2dea-32c4-40bc-8ad8-be8cd20440b8,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Congenital Anomaly Register and Information Service (CARS),,Not Rated,19.05,6fe7e004-eb51-4c7b-9905-1ec9a4827dca
38.1,3a56c317-bf1b-448d-89ab-3421eae3aa18,25.58,57.14,Not Rated,1.1.7,23.81,58.64,Death register,UK Biobank,Not Rated,42.86,722056a5-5fc6-4ad2-8efe-62a80dd6389b
33.33,3a880d1a-bd02-4d23-bca0-4b6ac45b09f1,55.81,36.5,Not Rated,1.1.7,60.32,31.62,SICSAG Daily (Scottish Intensive Care Audit Group),,Not Rated,19.05,811a54fb-8b79-442f-8e28-a725a0561a15
100.0,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,16.28,89.69,Gold,1.1.7,20.63,89.48,Annual District Birth Extract,ALLIANCE > SAIL,Gold,95.24,12a77014-4a77-4eb1-8b26-f49689352d1b
100.0,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,16.28,89.69,Gold,1.1.7,20.63,89.48,Emergency Department Data Set,ALLIANCE > SAIL,Gold,95.24,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c
33.33,3adb43c7-cc13-423a-9625-8fd571bbcb26,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Paediatric Diabetes Audit - Parent and Patient Experience measures,,Not Rated,19.05,b0979e07-3331-408f-853b-5eeba80ce8f9
92.06,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,18.6,84.92,Silver,1.1.7,22.22,84.75,IBD NIHR BioResource: Consent records,HUB > GUT REACTION,Silver,88.1,44ca2cf8-679e-447c-a9eb-55b32159679a
23.81,3b6d2dbe-0241-4c38-9038-2d6ce1e280de,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,ALLIANCE > HQIP,Not Rated,28.57,24b88d1a-4363-4619-870e-9ba9fc5d09e1
15.87,3b752633-8274-4418-b15b-4502bab03935,39.53,38.88,Not Rated,1.1.7,38.1,39.76,CDE Surginet Documentation,ALLIANCE > BARTS HEALTH,Not Rated,19.05,4c4bc482-16f5-462f-8daf-51ec6492074d
33.33,3b8357ac-bf06-44c4-9a43-8e772bec709c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,IBD NIHR BioResource: Demographic,,Not Rated,19.05,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1
33.33,3b84d205-2175-4c9a-bbe3-d0e24434e625,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Investigations, interventions, and outcomes for acute coronary syndrome",,Not Rated,19.05,b8f2c611-21d0-424e-a1ed-6976b1c207ec
57.14,3bb25cba-b4dc-47f1-ab5e-b63f89500612,18.6,69.05,Bronze,1.1.7,19.05,72.84,IBD NIHR BioResource: SNP imputation data,HUB > GUT REACTION,Bronze,64.29,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2
33.33,3c14d319-4ff5-42ff-b440-400f099f9b13,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Active Adult Survey Dataset (AASD),,Not Rated,19.05,1eb67fd5-33f6-49dd-a43d-854fff9f25f5
61.9,3c23941a-42a7-4940-b32f-aea743c0dc2a,18.6,72.22,Silver,1.1.7,17.46,76.42,Tissue Solutions Ltd,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,bbcdc352-e0f7-4672-93a7-134bcf5001b1
33.33,3c870bf2-acfb-44d1-8437-06ebb3c0993c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Postponed Admitted Procedures (CAPD),,Not Rated,19.05,bff94600-a254-4111-82f7-6167084d81ca
33.33,3cefb3f4-a463-4762-909b-3e4f3cef8e93,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COG-UK Viral Genome Sequences,,Not Rated,19.05,1fe02b65-7b77-43bf-93c8-4f0743fee672
96.83,3d51dc99-c44f-44ff-bdab-da205c5e394e,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London Outpatient Care Data (NWL OP),HUB > DISCOVER NOW,Gold,92.86,9f1df859-f1d0-4f1e-959e-affd05138a25
60.32,3db58c78-fc8b-49b2-a847-b43fd0184500,16.28,72.22,Silver,1.1.7,15.87,76.38,Ethical Tissue - University of Bradford,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,fdf9ac68-fc89-4adf-9a73-3a94a9974aef
33.33,3e4d27e2-baa8-4bb5-a711-d0b36f1f278c,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Diagnostic Imaging Dataset,,Not Rated,19.05,86f46be3-bc29-4820-8363-de6530a94c6f
4.76,3ed8d3fe-92a3-43bc-9fba-274fb34847af,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Higher Education Statistics Agency (HESA),,Not Rated,4.76,36f54a48-6f0a-4827-a86b-fd677a22a88f
4.76,3ee4c2af-ff04-4dcf-830e-420e0a21a6d2,46.51,29.36,Not Rated,1.1.7,46.03,29.12,mHealth for pneumonia prevention,,Not Rated,4.76,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd
60.32,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,16.28,72.22,Silver,1.1.7,15.87,76.38,Multiple Sclerosis and Parkinson's Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,4684d391-a6a7-44f7-bf4b-62b6b693f9fa
33.33,3f6962d8-1f4c-49b0-80a8-e491d5205827,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Outpatient Appointment Dataset,,Not Rated,19.05,1c27bfbf-c659-42ff-8afe-d58250b49c07
85.71,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,27.91,79.36,Bronze,1.1.7,26.98,75.33,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,ALLIANCE > BARTS HEALTH,Silver,78.57,d6e8163f-2ab8-4880-bbb6-a174b4a95632
85.71,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,27.91,77.78,Bronze,1.1.7,30.16,75.33,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,HUB > PIONEER,Silver,78.57,cfa1ef13-8ae0-4827-8a0f-9d2df5244725
33.33,3fcdcced-e16a-4f04-a521-ffe1047f37cb,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Paediatric Diabetes Audit - survey of workforce in PDUs,,Not Rated,19.05,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9
100.0,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,13.95,92.06,Gold,1.1.7,15.87,90.64,Cafcass Wales,ALLIANCE > SAIL,Gold,95.24,29a714e1-5289-4362-be24-2848c954344e
4.76,3fd2760d-ab12-48ee-8b32-b229aead60a4,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,,Not Rated,4.76,56130df6-1880-4600-a7a4-afa9a4bcc895
14.29,40573895-497b-4d47-90e1-6aafe70b93f6,37.21,38.89,Not Rated,1.1.7,36.51,39.73,Endobase,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,e830b2a5-14d6-4643-a206-619bf5372dc8
77.78,41a667eb-1c84-4665-b0d4-d26405d277c5,25.58,75.4,Bronze,1.1.7,26.98,72.93,Domiciliary Social Care Worker [DSCW],ALLIANCE > SAIL,Bronze,71.43,0e38bbf4-c788-4a1a-9af8-a24821250154
55.56,41ac5dfd-7b23-4f1b-a91e-03e8186e4ab8,16.28,69.05,Bronze,1.1.7,17.46,74.0,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,HUB > BREATHE,Bronze,64.29,4346676d-6108-47de-b579-6cef74c6acef
88.89,41ce265a-c252-45c4-9b80-d764b0737f38,27.91,79.37,Silver,1.1.7,30.16,76.52,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,ALLIANCE > CPRD,Silver,80.95,bfb90d2b-746d-44a6-a896-4979d73d9276
33.33,41f6dfe9-d5e2-4641-9953-1589c7d35e07,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Death Registration Data - Finalised Extracts,,Not Rated,19.05,fdfa5116-4f44-457d-99ef-e8c1852aa858
33.33,425e39b4-cc2b-4a15-851a-a0093ef1e1f8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma and COPD Audit (NACAP): secondary care  – CYP asthma (clinical),,Not Rated,19.05,33b36393-3760-40d8-bb98-61806fea5398
74.6,4262e057-6978-4e4c-a05d-c4f328422090,39.53,67.46,Not Rated,1.1.7,39.68,61.19,Mental Health and Learning Disabilities Data Set,ALLIANCE > NHS DIGITAL,Bronze,61.9,e9b43936-e700-40c9-8b32-57ed44583f3d
100.0,42ac7c27-a37b-4081-8a33-51ac077e6a4e,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Microbiology Cultures,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,9c1727f6-2032-413f-bf60-470769b2616e
33.33,42e4299f-1e06-4e24-ab40-b71949f5cba3,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Pathology - PATH,,Not Rated,19.05,48ef8f54-9606-4e6f-9256-3cc07ffd10b8
33.33,4330b6ee-f333-4cd8-90b9-0f43f7cb0b67,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Covid-19 Infection Survey linked with VOA and EPC data,,Not Rated,19.05,2193ad56-6671-4ecc-9ecf-6da84e23e9fd
90.48,4353b5fa-b3aa-4786-9e7f-4fb2273f5d3e,32.56,78.58,Bronze,1.1.7,33.33,75.38,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,ALLIANCE > CPRD,Silver,83.33,f8af632e-442d-4931-a370-b7fa2fa4b896
98.41,45499ef9-daca-4a88-8493-c3c1a92960d0,13.95,91.27,Gold,1.1.7,15.87,89.45,Welsh Ambulance Services NHS Trust,ALLIANCE > SAIL,Gold,92.86,d415a5c5-8432-4a81-937f-12135ade6de7
58.73,458d7f2d-9ba8-4593-862c-14160692d494,16.28,70.63,Silver,1.1.7,17.46,76.38,Asthma and COPD: practices and perceptions of GPs in rural India,HUB > BREATHE,Bronze,69.05,c15bc3ad-c053-496b-863f-1d54075d5bd4
33.33,459387f3-c484-441d-9abb-b6ee22df86d2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Public Health Research Database (PHRD),,Not Rated,19.05,a325f33e-bac8-49af-896f-1e025941dae8
77.78,46493a09-b3bb-4c0e-b944-82665ee21508,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38
23.81,46762bdc-42f9-4c92-92fe-9c757083ad33,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,ALLIANCE > HQIP,Not Rated,28.57,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9
100.0,46e30817-b19e-40f2-9b06-9611b2985148,13.95,92.06,Gold,1.1.7,15.87,90.64,Maternity Indicators Dataset,ALLIANCE > SAIL,Gold,95.24,a0c27454-8cbe-418f-bdae-a85d5e92e9d4
4.76,46f6e0d3-412e-4799-8683-1ca649b99eec,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Developing and Evaluating Interventions to Improve Asthma Care,,Not Rated,4.76,d57d7956-d13e-49c4-bb31-889b8e560596
23.81,4710222c-9830-4ae4-8be6-b25c723812e1,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,ALLIANCE > HQIP,Not Rated,28.57,fe6a4c83-f46f-4f61-8460-e120fdf8d864
60.32,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,16.28,72.22,Silver,1.1.7,15.87,76.38,Tayside Biorepository,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,6ac9b356-00f1-49da-825a-6eb04d18e49d
33.33,47e26b2b-8be1-4595-a327-a9f00e0d4712,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Consent records,,Not Rated,19.05,44ca2cf8-679e-447c-a9eb-55b32159679a
63.49,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,20.93,72.22,Bronze,1.1.7,19.05,75.25,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,425f4534-51c4-4f75-8ca0-d7c731dbd903
34.92,480ccd8a-309e-417a-ac23-5b2d9cd281b1,25.58,54.76,Not Rated,1.1.7,25.4,56.26,Genotype,UK Biobank,Not Rated,38.1,93a7352f-fce4-42c9-9a8c-efc7fe23eda0
96.83,48182af6-2ccd-44b2-92d5-69cc140e7d67,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London Primary Care Prescriptions Data (NWL PCP),HUB > DISCOVER NOW,Gold,92.86,0fb33df6-ab36-4170-9fad-1eaf35a3a812
33.33,483be944-b3ea-4037-b22b-4e9ffca3e613,51.16,41.27,Not Rated,1.1.7,50.79,33.95,A granular assessment of the day-to-day variation in emergency presentations,,Not Rated,19.05,ef850406-2993-43ec-80b9-ef504734f2ac
33.33,483f49ea-07b3-4efb-8bad-0d9af5ed5f0f,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry - Organisational Audit dataset,,Not Rated,19.05,3c661240-e4d2-456c-a809-133c23f9c469
90.48,484bff65-c47e-47ce-9eb5-5d381f961160,32.56,78.58,Bronze,1.1.7,33.33,75.38,Cancer registration data for CPRD Aurum,ALLIANCE > CPRD,Silver,83.33,3f3df3be-05a8-42b2-89d9-f731deb7ea66
23.81,489cb34a-f20d-4fe0-849a-db85f00141f5,34.88,44.45,Not Rated,1.1.7,34.92,46.84,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7
33.33,48deb24e-7a15-48d7-ba2c-c477ae61b55d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR BioResource: Sample holding,,Not Rated,19.05,56993820-96e4-4a1f-9de1-bad53108c201
23.81,491cc634-05e8-48fe-9018-ffb9e7eed84e,34.88,44.45,Not Rated,1.1.7,34.92,46.84,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",ALLIANCE > HQIP,Not Rated,28.57,949d9d7a-a3f1-480a-8563-3fb024300561
33.33,4a860548-406b-4a05-991e-0bc840e67974,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Health & Attainment of Pupils in a Primary Education Network (HAPN),,Not Rated,19.05,464d8653-4e69-406b-93fd-d68c29d5dfdc
33.33,4abe1436-3a14-4779-aa03-28929e817411,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside & Fife Radiology,,Not Rated,19.05,af10ec29-1866-4726-b33f-3948afe182f2
23.81,4b2fbd88-71c7-4572-99ea-5987a72a0c1a,34.88,44.45,Not Rated,1.1.7,34.92,46.84,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,ALLIANCE > HQIP,Not Rated,28.57,2c737d63-69f4-4a02-8df9-54c1e65e845f
4.76,4b3d70f4-ce62-478b-9ada-0419850d17af,46.51,29.36,Not Rated,1.1.7,46.03,29.12,South East London Community Health Study (SELCoH),,Not Rated,4.76,cda770e3-0d4d-466f-8102-c56beff04848
33.33,4b59ff6f-2830-4f2b-b35a-623ef4520eb8,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Systemic Anti-Cancer Therapy Dataset (SACT),,Not Rated,19.05,6c4ed998-0f05-415c-a3e4-42430bb62d24
98.41,4b6d3344-e73a-4f46-8e9d-fabb85827772,13.95,91.27,Gold,1.1.7,15.87,89.45,Daily Situation Report Data,ALLIANCE > SAIL,Gold,92.86,c74a9b9e-1fea-4aac-99fd-54e30668e085
33.33,4b79bce2-6d1c-448b-969e-56b424f3d57a,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Early Inflammatory Arthritis Audit - organisational survey dataset,,Not Rated,19.05,a9ac99fe-32be-40ef-9509-03e6b2713ddf
4.76,4c171540-5caa-42f7-868d-1d4d7b969f11,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Assessment of ASHA’s workload and its determinants,,Not Rated,4.76,1a02bc11-a378-4f9e-82f9-c52674b388bd
55.56,4cb9082f-619d-4be2-8d09-641f2c573d38,18.6,68.25,Bronze,1.1.7,19.05,72.84,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",HUB > BREATHE,Bronze,64.29,2581994d-5be2-4465-bb62-60c4c97e8e2b
60.32,4cde083a-bf5a-4f57-97c6-38632e10050d,16.28,72.22,Silver,1.1.7,15.87,76.38,Obesity Research Biobank Syndicate (ORBiS),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,264a1987-a8cb-4a83-81e0-70b4c3893b7d
23.81,4d0c3779-9251-4a4a-9eff-41a47869157f,32.56,45.24,Not Rated,1.1.7,33.33,48.0,National Oesophago-Gastric Cancer Audit - clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,306274ee-a098-43cc-b113-2df8116a8703
23.81,4d1271dd-b256-454b-9b13-be38bef73f15,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Paediatric Intensive Care Audit Network - core dataset (admission),ALLIANCE > HQIP,Not Rated,28.57,4ca76471-6970-4ad4-87c7-fae77a98cbf5
33.33,4d560a49-6ab2-460c-980f-94d76d1527f2,55.81,36.5,Not Rated,1.1.7,60.32,31.62,NIHR BioResource: SNP chip data,,Not Rated,19.05,c388676c-a5e5-419c-967c-239c1f0c3c5c
60.32,4dd3f23c-44be-4126-aac5-ba655d07855c,16.28,72.22,Silver,1.1.7,15.87,76.38,POUT-T,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808
33.33,4ee43bb7-54a1-40a9-9a2a-4f07cd5b1920,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Hospital Episode Statistics Outpatients,,Not Rated,19.05,d4362d41-0838-4f41-bba3-c3268312c444
4.76,4f3fff58-7c32-4879-8ac2-f3c7641fbb85,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Audit of Dementia Round 4 - carer experience survey,,Not Rated,4.76,3b5907da-256d-49a3-b24b-00893afe8bdd
23.81,501b0226-1cbf-4717-8dee-adf189dd0088,34.88,44.45,Not Rated,1.1.7,34.92,46.84,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",ALLIANCE > HQIP,Not Rated,28.57,11deee42-5876-4ebe-acca-e996702e1343
23.81,50609a73-30a0-46ca-847d-4a9c1bfec5fc,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),ALLIANCE > HQIP,Not Rated,28.57,3558f8a1-6d52-4b59-b513-51c068095bc2
88.89,50925199-a35d-4327-87cd-7761d713a72b,30.23,78.57,Silver,1.1.7,31.75,76.55,HES Outpatient data for CPRD Aurum,ALLIANCE > CPRD,Silver,83.33,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e
4.76,51221591-a4d4-4b9f-a220-b72d860d99fd,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Audit of Dementia Round 4 - staff questionnaire,,Not Rated,4.76,ef6e68d6-dcba-410c-943c-26ca21376a3a
33.33,51ad73b3-dd3e-44ad-b941-0d5d12bcb0cd,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Looked After Children Wales (LACW),,Not Rated,19.05,cfdafacb-48f0-4ad8-9f20-193a5eec2da4
15.87,5271131b-ba5b-452d-b230-077094a031c2,39.53,38.88,Not Rated,1.1.7,38.1,39.76,ARIA Dataset,ALLIANCE > BARTS HEALTH,Not Rated,19.05,621dd611-adcf-4434-b538-eecdbe5f72cf
88.89,52c784f6-99c6-4407-b660-abaa1682c955,32.56,76.19,Bronze,1.1.7,36.51,74.19,Mental Health Dataset (MHDS) for CPRD Aurum,ALLIANCE > CPRD,Silver,80.95,48627b2d-f247-4921-9ee1-6c37adfff10d
4.76,52db3903-e6c1-4f03-b6ee-909967fe3d16,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Respiratory rate counters in paediatric pneumonia diagnosis,,Not Rated,4.76,beeee4fb-55ab-41b0-9287-33f008e9d6bf
96.83,535a0983-6618-4211-a939-ae2edfe26f9a,20.93,84.92,Silver,1.1.7,26.98,85.97,North West London Adult Social Care Data (NWL ASC),HUB > DISCOVER NOW,Silver,92.86,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e
33.33,53846ac7-61b7-4403-8556-c319d04b546d,58.14,34.12,Not Rated,1.1.7,65.08,30.45,National Records of Scotland (NRS) - Deaths Data,,Not Rated,19.05,e600dae2-a83c-4b7a-8d23-af4ac31ca374
82.54,53b7c446-667b-409e-920e-67cb516de3ae,25.58,78.57,Bronze,1.1.7,25.4,74.12,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,HUB > PIONEER,Silver,73.81,cacba424-6c2c-4b57-8f5b-64e92a78370a
33.33,53dbbca0-b57d-4f93-8f05-37f626f9a7bc,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Scottish Medical Imaging (SMI) Research Dataset,,Not Rated,19.05,1c49a822-6432-468b-8ba5-6aab534654b9
33.33,542bf16f-baea-4fca-be51-fcef9732494a,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Cervical Screening Wales (SCSW),,Not Rated,19.05,b32325d7-7f00-4d20-9935-dd02e1bc6932
60.32,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,16.28,72.22,Silver,1.1.7,15.87,76.38,Epilepsy Society Brain and Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,f13258c3-f85a-4772-b42e-da8a84c5064a
4.76,55b311a8-7162-410c-8cf7-eef1ac9ff544,46.51,29.36,Not Rated,1.1.7,46.03,29.12,IBD Registry COVID-19,,Not Rated,4.76,ffdf167b-f3a3-4d78-a228-2865aea90509
60.32,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,16.28,72.22,Silver,1.1.7,15.87,76.38,LBIH Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,c0318a31-a32c-4d3a-9591-dfe9352bf2b9
4.76,567b5d24-07df-4430-8466-4444ecbe86c8,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Assessing the feasibility and effectiveness of introducing pulse oximetry,,Not Rated,4.76,2f36b7b3-e50f-459f-a691-f62dde65e2bd
60.32,56f3e791-a204-4f67-a4d0-52803148d71a,18.6,71.43,Bronze,1.1.7,17.46,75.22,TNT: Triple Negative breast cancer Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,5f4c825d-d6c3-453e-9667-8cdf2329b6e1
4.76,5727d014-0c5c-4dcb-89c9-ff33e1b680bb,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Wellcome Sanger Institute: Whole Exome Sequencing,,Not Rated,4.76,cd20517c-2f75-40e9-9ee8-563d32624b55
33.33,57458394-945e-4e6a-abc7-91df0f44cb60,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Health and Lifestyle Questionnaire,,Not Rated,19.05,18bfe765-5733-41f3-8114-0a1ec2524b5b
84.13,575514e3-6e8f-4218-bd75-ff32742abc52,25.58,76.19,Silver,1.1.7,31.75,76.5,Coronavirus and the social impacts on Great Britain,NCS > OFFICE FOR NATIONAL STATISTICS,Silver,78.57,e253257c-48c2-491b-b3b9-205161a16a7e
100.0,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,16.28,91.27,Gold,1.1.7,17.46,89.48,COVID-19 Test results,ALLIANCE > SAIL,Gold,95.24,f5f6d882-163d-4ef1-a53e-000fba409480
4.76,590e7bb7-a6e3-4f87-af2f-e46943f98ce9,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,,Not Rated,4.76,e0d00cb7-62e1-4a38-8df6-cf537b59228d
4.76,598ab9d9-04a3-4628-be64-d8f026d266ac,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,,Not Rated,4.76,cf9bc775-1db7-44e4-9a16-317d5bb063a2
4.76,59f5b724-234f-401d-a8f5-df35ea9ecdc9,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme - Percutaneous Coronary Interventions (PCI),,Not Rated,4.76,ac7016ce-f7a9-4c71-bebb-6af6efa27844
4.76,5a6009f8-c74a-4e72-b2a1-83be100f7841,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),,Not Rated,4.76,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103
33.33,5ad2e0c9-f0ba-4947-90f7-b19431080f83,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Primary Ankle Replacement dataset,,Not Rated,19.05,b8d009d0-0163-4aaf-8bd6-ad363c859862
33.33,5b456d15-cb68-4944-839c-c25a2986e572,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Longitudinal C-reactive protein concentrations in COVID-19: an OMOP dataset,,Not Rated,19.05,597524d4-038e-4fc2-aff9-1c9b87d3e16c
96.83,5b9b7964-615b-438a-b151-d2f884a24aee,20.93,84.92,Silver,1.1.7,26.98,85.97,North West London Accident and Emergency Data (NWL A&E),HUB > DISCOVER NOW,Silver,92.86,721db252-8069-433d-bb6d-4b44b243d364
60.32,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,16.28,72.22,Silver,1.1.7,15.87,76.38,VinCaP,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,e57dd7a2-3c5c-4285-8001-8e2589c395e9
42.86,5c7ae78d-53e6-427d-a3a9-52538f8342dc,30.23,55.55,Not Rated,1.1.7,31.75,61.08,International Severe Asthma Registry,HUB > BREATHE,Not Rated,52.38,9711e6cc-426c-4cef-afb3-64382f8d7ed4
33.33,5cd5a6a1-f7a2-4d83-a3e3-423495c3a281,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Education Daily Attendance Dataset (EDAD),,Not Rated,19.05,17056e83-ee5a-4fe7-86e1-f09563256be1
33.33,5ce6905a-8b54-4d6c-9da6-e2d57ce45419,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Waiting List Diagnostics,,Not Rated,19.05,e508951d-e118-4217-84a4-722e50fdd400
33.33,5cf49b5c-bb8d-4ab2-90ce-74d801f7c090,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Renal Register – ISD National dataset,,Not Rated,19.05,32edd77d-533c-423f-b045-937507f8505d
33.33,5d577e70-2b9b-4286-81f3-824978dc3069,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Moorfields Ophthalmic Prescription 004,,Not Rated,19.05,2ec8d8e3-35bc-4304-83e8-3afed4438cd5
33.33,5de9d313-fb9f-4dbf-a959-1329062eb1ef,55.81,36.5,Not Rated,1.1.7,60.32,31.62,NIHR BioResource: Case report form,,Not Rated,19.05,4b8675d3-dd87-4cca-804c-aaf0e4ff8140
14.29,5e022f8f-4d07-44bb-a87c-43e31200fe1e,37.21,38.89,Not Rated,1.1.7,36.51,39.73,ARIA Radonc,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,59d72237-6969-4f59-9e87-48138978abe8
33.33,5e044863-b792-4256-aa45-3235a6546e39,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Primary Hip Replacement dataset,,Not Rated,19.05,03280e87-6975-4a2a-967d-b332cb788e44
96.83,5e19a471-64e3-4aa4-ac56-6901d5e39e28,18.6,85.72,Gold,1.1.7,25.4,87.13,North West London Mental Health Data (NWL MH),HUB > DISCOVER NOW,Silver,92.86,2d3ec99a-a087-4355-8539-5a22cef58910
100.0,5e2a7277-dc64-499a-b16d-51850d9ad00b,16.28,89.69,Gold,1.1.7,20.63,89.48,Emergency Department Dataset Daily,ALLIANCE > SAIL,Gold,95.24,fa257aa8-51fc-4eb7-a448-e473fa54686d
33.33,5e442584-9acd-4e8d-9448-5f8f2b937d56,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Biochemistry (Lab Data Restructured),,Not Rated,19.05,10ffac16-d0c2-4d53-ab6a-69a38e283223
33.33,5e9d4a4b-544c-4739-b079-62f353086fde,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Moorfields AMD Dataset Release 002,,Not Rated,19.05,bf392537-82b4-4d71-ace0-e7bea3b167fb
87.3,5e9d9633-c4f4-47cc-96d9-350191e18539,27.91,78.57,Silver,1.1.7,30.16,76.52,HES Diagnostic Imaging Dataset for CPRD Aurum,ALLIANCE > CPRD,Silver,80.95,617f9f54-3fb6-40c3-b391-fe51d1fc7c49
33.33,5e9fba37-017b-4481-bc69-75ef1e005c2f,51.16,41.27,Not Rated,1.1.7,50.79,33.95,National Community Child Health Database (NCCHD),,Not Rated,19.05,20fe153c-a5e5-4991-900e-8fa9988e771a
33.33,5ef3573a-274a-41e1-8f64-9330109d59d1,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Cancer Registration and Analysis Service,,Not Rated,19.05,0a852454-ee67-443b-a091-d13499a71b41
33.33,5fdfa652-eda8-4709-89e0-02d8412851d4,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Covid-19 Infection Survey,,Not Rated,19.05,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf
100.0,601f1504-2706-405b-94cb-8cd14231f434,20.93,86.51,Gold,1.1.7,26.98,87.16,North West London population data (NWL POP),HUB > DISCOVER NOW,Gold,95.24,1032850f-7631-4d9e-a760-b0532bffd21a
33.33,602dc3ef-8c76-4ad4-941b-0a39e50481e7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Investigating the impact of frailty, age and illness severity during COVID-19",,Not Rated,19.05,108ba1b0-994d-449c-b192-2331698e477d
60.32,60b148f7-b48c-49c4-9286-b83691cfc7b2,16.28,72.22,Silver,1.1.7,15.87,76.38,STAMPEDE,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,71eb0192-1124-4b27-86e4-1139e0047a02
33.33,61b34cfb-041b-46a3-801d-1932b92795b9,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Weekly SUS Inpatient Dataset,,Not Rated,19.05,3858647c-5161-45dc-ba49-66a4fc4499c2
33.33,61df41f6-6d91-4144-b29d-489dd73c48a1,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 Wastewater data,,Not Rated,19.05,fa9c25eb-1ce0-4f44-b6a6-46ec8caeef40
100.0,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,20.93,88.09,Gold,1.1.7,23.81,87.16,GENOMICS ENGLAND 100K PHE LINKED DATA,GENOMICS ENGLAND,Gold,95.24,ea748742-568a-46e2-b603-2fada49024e1
30.16,62fef8d2-c397-43c3-b14a-69cf89423887,27.91,50.8,Not Rated,1.1.7,28.57,53.9,Vitamin D supplementation meta-analyses,HUB > BREATHE,Not Rated,35.71,2454a964-be58-4d1f-8f9a-ffae9db9129c
33.33,63f5c784-e0ee-46db-bbe5-279164033ed4,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Intensive Care National Audit and Research Centre - Covid19 (ICNC),,Not Rated,19.05,add6226b-0f21-439a-84a6-51dc26cdc425
33.33,6421830a-148d-4f86-8cd3-cefb5177610c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside Microbiology Lab,,Not Rated,19.05,826be5be-9977-49f9-b6d1-83ed9de08ebe
33.33,645168a0-21b1-4e13-85d8-266ad9040af8,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Suspected Cancer Pathway Monthly (SPCM),,Not Rated,19.05,fcf5a844-f48d-428e-aa06-abe64e66185e
33.33,6456c509-aa71-45de-b4f4-251448e45cbc,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Intensive Care National Audit and Research Centre (ICCD),,Not Rated,19.05,fa8bf269-4769-491b-b398-fa63137d14ab
33.33,645cb77f-30e7-42be-a07d-2384cee4966e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"A synthetic dataset of 15,000 ""patients"" with Community Acquired Pneumonia (CAP)",,Not Rated,19.05,a6575d98-0b2b-4c06-b9c6-88c1729257b9
4.76,646d65df-fc4c-4680-b949-79ec8f40b406,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"Trusted Research Environments for CVD-COVID-UK in England, Scotland, and Wales",,Not Rated,4.76,7e5f0247-f033-4f98-aed3-3d7422b9dc6d
33.33,649261ce-833f-459e-908c-2ef93c5fed41,58.14,34.12,Not Rated,1.1.7,65.08,30.45,Civil Registration - Deaths,,Not Rated,19.05,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a
90.48,65481fcf-cc98-44f0-bcfe-c21bcb8db0f5,30.23,79.37,Silver,1.1.7,31.75,76.55,HES Accident and Emergency data for CPRD Aurum,ALLIANCE > CPRD,Silver,83.33,c43501ec-08b4-4d33-a7dd-d19fca821925
33.33,658c4030-3a6d-4e67-abea-25601a478861,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Cancer Intelligence and Surveillance Unit (WCSU),,Not Rated,19.05,368ad790-3ad8-4f93-9a7c-0bfb64dc6015
98.41,65c8a30c-de2c-47bf-87e4-18c86e75e54a,16.28,88.89,Gold,1.1.7,20.63,88.29,Diagnostic and Therapy Services Waiting Times,ALLIANCE > SAIL,Gold,92.86,97896866-ab5e-408a-ac5a-072802db9faf
33.33,65ce36d2-f5fa-4a10-b210-b917fbb7c8a5,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Careers Wales Dataset (CARW),,Not Rated,19.05,e4004e0e-6adb-4b11-82c2-af0caf61d751
33.33,65eaa19c-e4b6-4611-922a-4be585a6d348,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Falls and Fragility Fracture Audit  Programme - Inpatient Falls clinical dataset,,Not Rated,19.05,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7
33.33,6615ba0a-9bcf-4a3b-8204-283c5e741b2b,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Fife Microbiology Lab,,Not Rated,19.05,0c43c0b6-de3a-478b-8190-4da37fbe5ff5
55.56,661b27db-38d4-4a9c-ac40-e3146ef12350,18.6,68.25,Bronze,1.1.7,19.05,72.84,Theory of Planned Behaviour Intervention: respiratory disease in South India,HUB > BREATHE,Bronze,64.29,7d23e729-72b0-4dd1-820d-07697b49acd0
60.32,6620b221-6909-4106-a49e-f1b5820be2f3,16.28,72.22,Silver,1.1.7,15.87,76.38,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,5ef75d71-73ce-4451-9d7a-a39dd82b712f
96.83,664513d6-d766-461d-a69e-206a928cd14f,25.58,83.34,Silver,1.1.7,30.16,83.64,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,Silver,92.86,d5049af5-e351-4b22-8f75-6f3dfc96419b
23.81,668eefeb-fb5c-46d8-a052-12fa8da4931b,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,becd2624-9a01-4f01-bcf8-56e94545a49a
33.33,670dbf72-0140-4228-b2de-4ad1ba1c920d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Scotland Accident and Emergency,,Not Rated,19.05,05e6752e-3a0b-4809-aa14-207b4761ef60
33.33,672a54ba-0b41-4573-adf8-e97158fad9bc,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Biochemistry,,Not Rated,19.05,10ffac16-d0c2-4d53-ab6a-69a38e283223
33.33,674c290e-36c6-4d9b-a908-a23e89a6745c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Haematology,,Not Rated,19.05,c294bb01-062b-494e-942b-1efe8cbac3dc
4.76,6762c371-8f4a-4511-910a-faf85760eab2,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),,Not Rated,4.76,3cc81e6c-0c17-4ccd-8202-a9aceb82c989
33.33,67ab8a56-99d7-4951-aacb-5dca0b8ffa35,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Waiting List Clock Stops,,Not Rated,19.05,3f073707-50b4-48cf-93b6-76843519a5c0
71.43,67cd0c2b-3944-4bc4-a03a-4081ee67847f,11.63,79.37,Silver,1.1.7,12.7,84.66,Genetics of Asthma Severity & Phenotypes,HUB > BREATHE,Silver,80.95,6277abc6-c039-4886-8489-d4a2cdb8190c
33.33,682b4d85-732a-4440-922d-07191a604143,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK Renal Registry - AKI Lab Alerts Dataset,,Not Rated,19.05,c38541a7-cf43-4bfd-928d-75613abc8e3f
33.33,68906d25-384c-4152-86b5-50c5170ad94c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Epilepsy 12 - clinical audit,,Not Rated,19.05,1fcaf429-8762-454c-b999-c5fdd757b880
33.33,69220bf9-f223-4e88-91c8-8ae8eab9f438,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,,Not Rated,19.05,49e63323-e564-48ac-9f11-cf77bf0fe20b
33.33,693fd389-a3a9-4cc9-9a13-6218d84292fd,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Business Insights and Conditions Survey (BICS),,Not Rated,19.05,8e739a01-bcfa-4b75-b7f8-e694ee185f8d
33.33,69833273-2b81-4657-8d80-5bafb2c0834d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,"Deaths – CHI, Community Health Index",,Not Rated,19.05,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406
23.81,6a11bc97-b57a-458f-8a3e-98c71221cb5c,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,ALLIANCE > HQIP,Not Rated,28.57,8a3ec96a-0600-4c6d-8761-9d277f07b9da
96.83,6a390359-1e26-470f-a4e5-bfb31a5ed643,16.28,88.1,Gold,1.1.7,20.63,88.29,North West London Patient Index (NWL PI),HUB > DISCOVER NOW,Gold,92.86,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0
80.95,6a63513f-92cb-43ce-b0dd-fdb1113150c9,32.56,72.22,Bronze,1.1.7,36.51,70.62,Mental Health Services Data Set,ALLIANCE > NHS DIGITAL,Bronze,73.81,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d
33.33,6a9a3c4c-95d4-45da-9520-c3b9aceb6d13,51.16,41.27,Not Rated,1.1.7,50.79,33.95,UHB Linked Diabetic Eye Disease from National Screening to Hospital Eye Care,,Not Rated,19.05,7c087b3c-cc04-4d3d-894b-7ea5419fa714
74.6,6ae22437-38d7-4c47-b529-e100e15c81ab,25.58,73.81,Bronze,1.1.7,26.98,70.55,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,HUB > PIONEER,Bronze,66.67,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4
63.49,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,16.28,73.81,Silver,1.1.7,15.87,77.58,York Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,71e898d1-db8c-4887-a605-dd6336b92a34
33.33,6af010f2-5973-486f-a44b-ef296455bee6,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Moorfields AMD Dataset 002,,Not Rated,19.05,bf392537-82b4-4d71-ace0-e7bea3b167fb
66.67,6bc36f07-d55a-4a97-afab-29d93dc65bde,20.93,73.81,Silver,1.1.7,19.05,77.63,Sheffield Brain Tissue Bank (SBTB),ALLIANCE > TISSUE DIRECTORY,Bronze,76.19,bdda7221-7c02-4ced-b7a8-3806a073d981
61.9,6bca5d27-5b98-45e7-b834-6980ba5db5c9,16.28,73.02,Silver,1.1.7,15.87,76.38,Leicester Respiratory Research Database,HUB > BREATHE,Bronze,69.05,01c3d08c-6948-4059-a027-3437e4f5d53b
60.32,6bde3902-5d69-4c24-9d10-f84a63efdb22,16.28,72.22,Silver,1.1.7,15.87,76.38,Leeds Breast Research Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,2dc1218d-df5f-4025-826c-cf5ca7d67882
33.33,6c12c555-c011-4f43-b98f-df0bfaad6b05,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Moorfields Eye Image BioResource 001,,Not Rated,19.05,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc
4.76,6cae7a61-568d-40b1-984a-1dd9365f9c71,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Effects of second-hand smoke on pregnant women: a phenomenological study,,Not Rated,4.76,4a5c610f-019d-450a-90c5-0fe315027f56
23.81,6cd16bca-395b-4dbc-a817-15fd55a1a8e8,32.56,45.24,Not Rated,1.1.7,33.33,48.0,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,03e77b9d-57b8-44d5-8d64-9b1325958b22
63.49,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,20.93,71.43,Bronze,1.1.7,20.63,75.25,DARWIN1 Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,7f9672fa-dad5-479d-a929-52719e8cc2fa
4.76,6dd170f2-c9fe-4496-9499-26783d84e3c2,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Exploring Personal Preparedness and Self-Protective Measures during COVID-19,,Not Rated,4.76,680a7d41-0fd1-4b32-a2cd-190e338f8ac7
53.97,6dd62b6b-d832-4c65-a101-20fe9edd75fc,20.93,66.67,Bronze,1.1.7,20.63,70.48,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",HUB > BREATHE,Bronze,61.9,dae5b81c-db28-414b-9328-5596632a8732
60.32,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,16.28,72.22,Silver,1.1.7,15.87,76.38,Wales Cancer Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,37886fb5-d0ae-400f-89eb-78664897bcf2
33.33,6e47173e-651a-404e-a0b2-1fa1cbd887b1,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Covid-19 Second Generation Surveillance System,,Not Rated,19.05,fede31c6-a9c5-4cfb-9866-9b58b2199cff
36.51,6e5916d4-017c-4542-bc71-edf6d4c5a055,25.58,56.35,Not Rated,1.1.7,23.81,57.45,Biological samples,UK Biobank,Not Rated,40.48,41ac38b0-31cd-4865-a357-80ce557b2312
23.81,6e70b32a-dfbc-46d3-9784-479f3f09527e,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,ALLIANCE > HQIP,Not Rated,28.57,4b33fc6d-3cac-4404-adac-d693328456fa
33.33,6e92101b-a660-4854-9a19-040324b6c9b3,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Annual District Death Daily (ADDD),,Not Rated,19.05,584bf8c8-d58f-44c6-9b65-e1611144fd54
4.76,6eef1d16-2283-4932-aa6c-c71ae7fa9e3e,46.51,29.36,Not Rated,1.1.7,46.03,29.12,TwinsUK,,Not Rated,4.76,19b4cd38-3828-4bb1-a980-4f7420658965
90.48,6f348bdc-21e4-459b-b658-dc839a1e2133,23.26,81.75,Silver,1.1.7,26.98,80.03,Intensive Care National Audit and Research Centre,ALLIANCE > SAIL,Silver,83.33,fa8bf269-4769-491b-b398-fa63137d14ab
33.33,6f9a4cb1-7c5a-4671-838a-9554a6491266,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Early Inflammatory Arthritis Audit - patient survey,,Not Rated,19.05,e87410ec-a819-43db-99d1-f887c977e525
33.33,6fbdc930-be40-4492-ba79-82d06d49b539,53.49,38.88,Not Rated,1.1.7,55.56,32.78,"NHS Tayside A&E, Diagnosis dataset during A&E visit",,Not Rated,19.05,14a39e96-8ac3-4df3-b42b-07718121c585
33.33,6fd8abda-7e49-436c-9131-a1f607569c14,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Covid-19 UK Non-hospital Antibody Testing Results,,Not Rated,19.05,a77e52cc-d404-45d6-835f-32e2dc46778a
33.33,6ffc7fd8-732f-4360-b38b-fa94dd75a13d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,"NHS Tayside A&E, Diagnosis During A&E visit",,Not Rated,19.05,14a39e96-8ac3-4df3-b42b-07718121c585
33.33,7017aede-b38a-4b70-b7b2-aade001d0cc0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,School Workforce Annual Census (SWAC),,Not Rated,19.05,5692eade-5738-48ed-8527-39be9caaa7b5
33.33,70491568-676d-43e4-b3c3-b1db4f1ff530,55.81,36.5,Not Rated,1.1.7,60.32,31.62,National Records of Scotland (NRS) - Stillbirth Data,,Not Rated,19.05,dca0c95b-ae7d-4163-8c3b-a881f779df02
33.33,705f86b8-4c2f-4ed5-b792-3a0d49d14c75,51.16,41.27,Not Rated,1.1.7,50.79,33.95,GoDARTS,,Not Rated,19.05,8ca05f55-af73-42bd-b682-851c2c54a6cc
33.33,708839a0-d003-4917-bbd9-92741f54ab75,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Waiting List Clock Starts,,Not Rated,19.05,2b847fd2-0f65-43b7-84e1-10cec99d699e
33.33,70ad0b2c-a8dd-4f91-a5b8-adca272bf215,55.81,36.5,Not Rated,1.1.7,60.32,31.62,BathTAP Switching Cohort 3,,Not Rated,19.05,a20643c7-ef15-4f7d-9e48-5a9f23a645c1
60.32,70b4d407-288a-4945-a4d5-506d60715110,18.6,71.43,Bronze,1.1.7,17.46,75.22,CASPS: A Phase II trial of Cediranib in ASPS patients,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b
4.76,70c318c4-b388-4102-924e-5419d44c1679,46.51,29.36,Not Rated,1.1.7,46.03,29.12,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,,Not Rated,4.76,009bcb87-05f3-46e6-8866-7e4df698cb19
33.33,719dd9c9-9aa5-426d-981a-57f0ad3f1480,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Moorfields DMO Dataset 003,,Not Rated,19.05,120106fb-49b4-4bc0-b30c-50a59c5c6253
65.08,71b8569c-b582-499c-85aa-909b825f6ea6,16.28,74.6,Silver,1.1.7,15.87,78.77,Avon Longitudinal Study of Parents and Children,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,Bronze,73.81,255d70c6-9a50-4b62-adc0-44216606a216
4.76,7257d45c-6697-4c49-bbce-de0d456c0678,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR BioResource: SNP imputation data,,Not Rated,4.76,39d7ad29-be30-4e12-a7c8-d8757141de85
33.33,72eb9599-aa37-4c17-bc56-a7833e8038db,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Paediatric Diabetes Audit - survey of diabetes-related technologies,,Not Rated,19.05,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f
14.29,72fe91de-b0c0-423a-ad68-bd7067b20ad8,37.21,38.89,Not Rated,1.1.7,36.51,39.73,Infoflex Cancer Registry,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,5505e91d-9e0a-4969-87d5-00f256d91306
85.71,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,23.26,80.95,Silver,1.1.7,23.81,77.66,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",HUB > PIONEER,Silver,78.57,16a09f1b-3654-4ec3-9913-fb70cb1e2364
69.84,73462506-32c5-43a0-963e-06d67e967b97,9.3,79.37,Silver,1.1.7,11.11,84.63,UK BiLEVE Consortium Dataset,HUB > BREATHE,Silver,78.57,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa
33.33,73941d19-6fcd-40e9-a7bd-ef0d91f93de9,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Critical Care Minimum Dataset,,Not Rated,19.05,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993
100.0,73f54071-62bf-48f5-8be1-569208b18ab8,34.88,80.16,Silver,1.1.7,39.68,80.18,HIC Hepatitis v2,NIHR Health Informatics Collaborative Viral Hepatitis Theme,Silver,95.24,66be725a-b950-4bf8-9a35-7e33ce765a25
60.32,74241b17-23b7-4233-b7b9-1a484aa053b0,16.28,72.22,Silver,1.1.7,15.87,76.38,Myeloma XII clinical trial samples,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,576fbcf8-ff25-4230-ae69-e72ca02b95f1
33.33,747d57aa-a02b-411c-9403-2e3ec9d3e5b5,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Contact detail,,Not Rated,19.05,02ddc5c9-03d4-40e4-9934-e60817ec8f3e
4.76,74b54e34-0e01-4447-be1d-e9da3e03cd2e,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR BioResource: Metabolite data,,Not Rated,4.76,dec09f2e-a93f-41e2-8217-72431ea4a19e
4.76,74be1c67-ab42-4716-a63b-be3f5de0d489,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Audit of Dementia Round 4 - casenote audit,,Not Rated,4.76,587a94e6-48a4-4e5e-8230-4018897bc7c7
38.1,75614b69-bc18-416b-9d27-fd8ca9fc4521,27.91,56.35,Not Rated,1.1.7,25.4,57.48,Cancer register,UK Biobank,Not Rated,42.86,a4751434-54ea-4d22-a66a-a5d32bd80c40
33.33,75dabfb3-69b7-4192-b257-d0d814e5872d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Paediatric Diabetes Audit - core clinical dataset,,Not Rated,19.05,e355c9b9-44f0-4ba3-a872-645aa88f4f2b
33.33,76535d6e-ce0c-407c-ba22-1b2420a1e654,51.16,41.27,Not Rated,1.1.7,50.79,33.95,National Exercise Referral Scheme,,Not Rated,19.05,131784c0-769d-4f7b-b7d0-b5f4b89886d4
33.33,77422eb1-7bdb-4205-b3d0-57d1add35317,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Moorfields DMO Dataset Release 001,,Not Rated,19.05,120106fb-49b4-4bc0-b30c-50a59c5c6253
100.0,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,13.95,92.06,Gold,1.1.7,15.87,90.64,The National COVID-19 Chest Imaging Database,NHSX,Gold,95.24,31f0148b-f965-4136-ab39-6c5bbbf8c2d9
63.49,7793f54e-73be-4c97-a941-ba105b1b0480,16.28,73.81,Silver,1.1.7,15.87,77.58,Leeds Multidisciplinary Research Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,7e60a651-b3d6-40ef-93dc-1f87dabee7be
33.33,77b48222-3a00-4dcc-b0ef-3f99dfae697e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Lifelong Learning Wales Record (LLWR),,Not Rated,19.05,cba62a8d-5917-4912-ad4d-340472f7b904
33.33,77dc7118-443c-4c85-a18c-e7bbe01e9e7a,55.81,36.5,Not Rated,1.1.7,60.32,31.62,1958 National Child Development Study - Pain data,,Not Rated,19.05,33092502-12ef-4bc0-8400-5f63915cbf33
33.33,77f4f3ec-31aa-4eb9-8896-a063ce831c9b,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Maternity Indicators Dataset (MIDS),,Not Rated,19.05,a0c27454-8cbe-418f-bdae-a85d5e92e9d4
46.03,7858978f-30e8-42e7-abe4-d9af5447c278,46.51,47.62,Not Rated,1.1.7,50.79,44.6,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,Not Rated,35.71,10ffac16-d0c2-4d53-ab6a-69a38e283223
63.49,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,16.28,73.81,Silver,1.1.7,15.87,77.58,UCL / UCLH Biobank for Studying Health and Disease,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,ce533c67-5565-4010-bedf-dca3863a9084
100.0,78ce070c-84db-4676-81c5-0c672f4e12e3,13.95,92.06,Gold,1.1.7,15.87,90.64,COVID-19 Symptom Tracker Dataset,ALLIANCE > SAIL,Gold,95.24,594cfe55-96e3-45ff-874c-2c0006eeb881
77.78,78fe2e13-7f40-406f-a584-04909d0ce060,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,64.29,efecbe58-4822-4f17-bf5c-92113d143db9
33.33,7964fc83-017a-4786-918e-bab61f7ddd99,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CAPS,,Not Rated,19.05,a4c595a6-cb41-4743-bea3-feb4d4c72091
33.33,796d97b4-6f3d-4ee8-8966-9238efdcac2d,53.49,40.47,Not Rated,1.1.7,52.38,32.78,Synthetic Dataset - Patients at risk of sudden death: hypertrophic cardiomyopathy,,Not Rated,19.05,7b1c1f1a-4fb2-452d-9a3c-7748992b1fa4
63.49,79b02690-798b-462d-9ced-f53c9e39d624,18.6,73.02,Silver,1.1.7,17.46,76.42,Central England Haemato-oncology and oncology Research Biobank (CEHRB),ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,314953f6-58e7-49c0-adfd-c60e623eba74
77.78,7aa02796-787a-42c2-b97e-d008fa77e4b8,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4
33.33,7aa38c5c-771c-4157-a008-32051a5aed4b,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Education Wales (EDUW),,Not Rated,19.05,204fa806-071d-4410-9c2c-143017d32d24
33.33,7ada943a-083d-44c5-a147-32e581e3ed20,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR BioResource: Contact detail,,Not Rated,19.05,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4
33.33,7b0071f9-ca68-46b2-b7ad-bc9a70a9ea0b,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Demography,,Not Rated,19.05,b88c2b24-b75d-4d28-9391-2dbac1605a17
4.76,7b922498-1757-418d-96ca-64980a50b647,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR BioResource: Whole Genome Sequencing,,Not Rated,4.76,ecb90b4a-6f4f-4398-a4f6-d64891c4a137
33.33,7d313fa6-941f-48ca-93e1-05d912d183ac,51.16,41.27,Not Rated,1.1.7,50.79,33.95,GPES Data for Pandemic Planning and Research (COVID-19),,Not Rated,19.05,696cfc9f-090d-4328-94ac-140760a77c73
33.33,7d414fa8-565b-451b-bc9c-fe2965c2bc5b,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Children In Need Census Wales (CINW),,Not Rated,19.05,e4f6d9a8-88d0-4781-b192-cd165451b272
33.33,7d6ec229-dbde-4e4e-91de-6b7d8111d02e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Results Reports Service (WRRS),,Not Rated,19.05,71d37610-ac55-432d-82a3-bdb04407acd8
33.33,7d98182a-18f8-4f2e-a59c-5048580557b5,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Early Inflammatory Arthritis Audit - clinical dataset,,Not Rated,19.05,b0797c05-352f-455f-8d27-150b6f6354cc
33.33,7daacbe5-082d-4c12-b801-0fb08932dada,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID-19 Vaccination,,Not Rated,19.05,b0049073-3335-433d-bdb9-de22547698f8
41.27,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,25.58,57.94,Not Rated,1.1.7,25.4,61.02,Effect of personal air pollution exposure on asthma control in children,HUB > BREATHE,Not Rated,47.62,57efab41-65fc-4069-8b9d-e5ced13cb4d3
39.68,7e780260-e8d3-4541-b51e-213233dfc349,27.91,56.35,Not Rated,1.1.7,26.98,58.67,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,HUB > BREATHE,Not Rated,45.24,36a5da45-772c-4c67-8ec3-84c9e67332d3
4.76,7ec7c8c4-770b-41f0-87d0-38ea232ae5bd,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Next Steps,,Not Rated,4.76,0ad7a3dd-e720-49ef-9d27-c394a32b0326
33.33,7ed08209-f22e-4cdf-b8b5-e1d58b0bcaf9,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),,Not Rated,19.05,04cb9964-54fb-4529-b09b-735c3daa1c7b
95.24,7f4fb30c-2a09-4d75-bed2-114751e06723,23.26,84.92,Silver,1.1.7,25.4,82.42,UHB Eye Image Dataset Release 001,HUB > INSIGHT,Silver,88.1,21fb56d1-726f-40e3-a998-e4b34ba3e46f
33.33,7f7860ee-6235-4e7d-95f3-df692f5d9630,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CDE Encounter,,Not Rated,19.05,3598723f-62fb-4377-9a8b-b264ced1aabd
100.0,7fdb684d-bb7a-4d0b-8666-9f10510f071f,25.58,84.92,Silver,1.1.7,30.16,84.83,GENOMICS ENGLAND 100K CANCER & COMMON,GENOMICS ENGLAND,Silver,95.24,702f0198-bdfe-401e-97f2-35f5d26357ad
82.54,80a7208f-c174-42bd-9127-e8f006de7c95,23.26,77.78,Silver,1.1.7,26.98,76.47,COVID-19 Test Trace and Protect [CTTP],ALLIANCE > SAIL,Silver,76.19,c0fc84af-aeab-4c7e-aa0b-8264baff55d9
100.0,80e9c439-4909-4534-8bfe-6f01fdec7de7,13.95,92.06,Gold,1.1.7,15.87,90.64,Cervical Screening Wales,ALLIANCE > SAIL,Gold,95.24,b32325d7-7f00-4d20-9935-dd02e1bc6932
33.33,80fc6c81-dd24-4f5f-870e-6c1cb7a1766d,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Outpatient Database for Wales (OPDW),,Not Rated,19.05,d331159b-b286-4ab9-8b36-db39123ec229
33.33,8193e951-2ed8-4ccf-9fe5-5c2e6f933d60,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Outpatient Dataset,,Not Rated,19.05,d331159b-b286-4ab9-8b36-db39123ec229
90.48,81a2abb5-e2b4-4224-8345-5aac1dc68a5d,32.56,78.58,Bronze,1.1.7,33.33,75.38,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,ALLIANCE > CPRD,Silver,83.33,014e7973-b43e-4a4a-91b4-de3f353b71b9
33.33,81c28c63-7cbb-49ce-86b4-c83e1c15fdba,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Weekly SUS Outpatients Dataset,,Not Rated,19.05,572cd3e2-9119-40ff-ab2e-49e8a0a02ab8
84.13,81c54c5a-ceb1-487c-820a-437b4dd002ca,25.58,79.36,Bronze,1.1.7,25.4,75.31,Risk and outcomes of coagulopathies in acutely unwell adults,HUB > PIONEER,Silver,76.19,bf3fe16c-5377-4571-b5a5-7aa7e796594c
88.89,81f3bdfe-de6b-4831-ba9a-4e28a34a6ab4,30.23,78.57,Silver,1.1.7,31.75,76.55,HES Outpatient data for CPRD GOLD,ALLIANCE > CPRD,Silver,83.33,21dc2345-3983-4a46-960c-f17974bc7b71
77.78,8226b6fa-d815-4f15-9064-b56beb0fddb1,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,64.29,a27400b0-0efb-4af8-a7bc-e2c7e59796e3
66.67,826114ca-2563-4c0c-b023-3417ead32956,20.93,73.81,Silver,1.1.7,19.05,77.63,Research Donors Ltd,ALLIANCE > TISSUE DIRECTORY,Bronze,76.19,fcb62cb3-c876-47a3-961e-fb27c6f718fa
33.33,8286eef9-0533-488e-bf19-8fc0fa1dd00b,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Immunology (Extractable),,Not Rated,19.05,39055449-c074-4b58-adb2-b1c0d2441c4d
4.76,828bc515-6b42-4492-a77e-cf20226ba041,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Reasons for delay in seeking care for pneumonia in children under five,,Not Rated,4.76,46f50b9b-b8e2-4ff1-a1b3-779174c3d032
63.49,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,16.28,73.81,Silver,1.1.7,15.87,77.58,Northern Ireland Biobank (NIB),ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,c6e1ea88-f5bf-4a57-953f-688f313fcb04
4.76,830c22bb-4321-4fa3-ba04-be9b30518877,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Hypertonic saline nasal irrigation and gargling for suspected COVID-19,,Not Rated,4.76,574cf7bc-dd70-4508-a66d-ac59d8d06639
4.76,83e177bb-5a05-4ec1-be22-272a0f985957,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Trusted Research Environments for CVD-COVID-UK / COVID-IMPACT,,Not Rated,4.76,7e5f0247-f033-4f98-aed3-3d7422b9dc6d
55.56,842e8c5c-a298-4942-9ac4-f95d1a5f87b3,27.91,64.29,Bronze,1.1.7,26.98,67.0,Deriving and validating a clinical prediction rule for the diagnosis of asthma in primary care,HUB > BREATHE,Not Rated,61.9,b0a68ee7-742d-45dc-aae9-4be4e1655fc0
100.0,844f3be0-f50d-4a88-9783-0928ad1c2aad,32.56,82.54,Silver,1.1.7,34.92,81.34,HIC Acute Coronary Syndromes,NIHR Health Informatics Collaborative Cardiovascular Theme,Silver,95.24,869a9b4e-3537-449f-9a59-a0eac523c4e4
60.32,8466ec6f-8a4c-4286-8138-04c35e12b1f8,16.28,72.22,Silver,1.1.7,15.87,76.38,"Oncology Clinical Trials Office, University of Oxford",ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,4a65f6d6-f2e4-4d98-a3a4-94a32206836d
23.81,849d46e6-49a6-4456-a5ae-990c02012bf2,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,ALLIANCE > HQIP,Not Rated,28.57,c3e63860-bd61-4154-ab5f-ca927fb029c4
39.68,84b6d047-2a05-4fc0-8537-809dbb3d18ed,23.26,58.73,Not Rated,1.1.7,22.22,60.99,COMPARE,OTHER > The University of Cambridge,Not Rated,45.24,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996
14.29,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,37.21,38.89,Not Rated,1.1.7,36.51,39.73,CRIS,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,67cea834-33f5-4ed7-9dc2-072ad077de07
96.83,850f99cb-f091-4f10-86ee-06a3eaa7df53,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London Coordinate My Care (NWL CMC),HUB > DISCOVER NOW,Gold,92.86,c853b41b-fbd1-4896-b0fb-85303109fec4
100.0,8638e095-a609-463f-b36e-c4cac4519660,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Tendon Rupture,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,4fcc8b11-2b9b-4f68-b51a-978749d89acc
60.32,865f0e79-f862-493b-b863-b39b777d60ca,18.6,71.43,Bronze,1.1.7,17.46,75.22,Oxford Musculoskeletal Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,ccd6e59d-3582-4f47-a4cd-f5845192d75c
68.25,8665b36e-f9a5-4062-ba56-d33fecfe3376,11.63,77.78,Silver,1.1.7,12.7,83.47,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),HUB > BREATHE,Silver,78.57,cc6f926a-90cf-4083-84e7-131d1e63813b
76.19,86d7088b-7a15-4e9a-b2b0-857a67e04650,37.21,67.46,Not Rated,1.1.7,41.27,63.54,HES:Civil Registration (Deaths) bridge,ALLIANCE > NHS DIGITAL,Bronze,64.29,21aec912-444f-447d-b3c4-6791a6c82667
90.48,88155e0d-a88f-4a72-ba3f-45d4e352439a,32.56,78.58,Bronze,1.1.7,33.33,75.38,Cancer registration data for CPRD GOLD,ALLIANCE > CPRD,Silver,83.33,e2f5d637-94b3-447b-b7eb-ea957ce449b6
41.27,8821748d-9d8b-4787-91cc-0a58c5ab890d,23.26,58.73,Not Rated,1.1.7,23.81,62.18,EMEP4UK Pollution,HUB > BREATHE,Not Rated,47.62,eb76598f-e228-413c-82f3-231809062611
60.32,88576066-fb5f-43e2-8af4-0904630b2f1b,16.28,72.22,Silver,1.1.7,15.87,76.38,University of Southampton Faculty of Medicine Tissue Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,786563e9-5377-4d18-8d32-65ff14d53987
90.48,8895d3d9-78bd-4216-986a-3bb7f864c382,30.23,79.37,Silver,1.1.7,31.75,76.55,HES Accident and Emergency data for CPRD GOLD,ALLIANCE > CPRD,Silver,83.33,733b1060-f958-4c3e-ab6a-2b87901d9a9a
77.78,895e5c2f-e484-4d08-91c6-35ac2f85c231,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v2.6 (Non-Sensitive),ALLIANCE > NHS DIGITAL,Not Rated,64.29,702201ff-e729-4e29-a428-32953c9a0332
60.32,89aac17d-f8a1-4ddc-9495-4adc278234a9,16.28,72.22,Silver,1.1.7,15.87,76.38,Human Biomaterials Resource Centre,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,2f085ac6-d33d-4b9b-8a99-624cc51c3f17
85.71,89f76cff-03dd-47a1-b6fc-29e42b78e7a5,27.91,78.57,Bronze,1.1.7,28.57,75.33,Hospital Episode Statistics Admitted Patient Care,ALLIANCE > NHS DIGITAL,Silver,78.57,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9
33.33,8a0d67e2-6daa-4ebe-913b-eb5ede8801ba,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Studies Supported by NIHR CRN, ICD10 Coded, with Summary Site Recruitment Data",,Not Rated,19.05,02397c83-62e6-4ec2-8366-89d211739564
33.33,8a4d097a-3ef2-4452-b6e0-98e2baebb427,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Primary Knee Replacement dataset,,Not Rated,19.05,d517e6fc-9a88-4647-b787-dcbed3635885
100.0,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,16.28,89.69,Gold,1.1.7,20.63,89.48,COVID-19 Consolidated Deaths,ALLIANCE > SAIL,Gold,95.24,70e37f44-5c3e-4c83-a42a-89b3476d1d45
33.33,8bbfbc8c-dad2-4a0b-b255-4aae3687a371,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Revision Ankle Replacement dataset,,Not Rated,19.05,b4f076d2-c9a3-49ba-84f4-94148dc8511a
15.87,8c7abca7-4292-4d1f-b311-c132a7adf109,39.53,38.88,Not Rated,1.1.7,38.1,39.76,Sectra PACS,ALLIANCE > BARTS HEALTH,Not Rated,19.05,10bf4c08-6702-44fe-8faa-1280dea6b0c9
23.81,8c8cf129-e87c-46b3-8812-19e07578ee89,34.88,44.45,Not Rated,1.1.7,34.92,46.84,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,d94a604c-5733-4f07-93bb-e77b6ea2313f
88.89,8d06cb09-640c-40db-8387-adf7fab54c3b,25.58,81.75,Silver,1.1.7,25.4,77.69,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),ALLIANCE > CPRD,Silver,80.95,83059be4-071b-4a36-8ab1-9fde1e32e75e
88.89,8d24889c-ac3c-4b9d-a8bd-cf9effd64370,25.58,81.75,Silver,1.1.7,25.4,77.69,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),ALLIANCE > CPRD,Silver,80.95,3bc43876-507b-4dff-bd2b-7df147322e15
33.33,8d33b7a7-151a-4e2e-b87f-b14371e0cb37,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Deaths – Date of Death,,Not Rated,19.05,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406
77.78,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,39.53,67.46,Not Rated,1.1.7,42.86,62.38,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,ALLIANCE > NHS DIGITAL,Bronze,64.29,31bb8022-f8b1-405a-a22f-140f7c4b4fa6
4.76,8da6766c-df44-4414-a858-4415e473ea76,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,,Not Rated,4.76,216924f0-585e-4842-a165-78cf9e0af0aa
4.76,8daf5886-4813-465d-9145-3585a8c584bb,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Asthma and COPD Audit Programme (NACAP): Wales primary care dataset,,Not Rated,4.76,8a3ec96a-0600-4c6d-8761-9d277f07b9da
69.84,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,32.56,65.87,Not Rated,1.1.7,38.1,64.67,REal-time Assessment of Community Transmission (REACT-2),ALLIANCE > IMPERIAL COLLEGE LONDON,Not Rated,61.9,25003f25-384c-4264-9c8f-dd8734ee5595
33.33,8e75e0f9-40ed-4505-a8e8-20f21c69ddea,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Children Receiving Care and Support Census (CRCS),,Not Rated,19.05,fb3fac03-a428-4b3f-8058-5622e1fd57d8
46.03,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,32.56,57.94,Not Rated,1.1.7,30.16,57.53,Mental Health Services Data Set - Inpatients,ALLIANCE > NHS DIGITAL,Not Rated,47.62,275ac6a4-798b-4f49-a25e-008245050bbc
33.33,8f2cb486-6a3b-418e-8fb4-b85bc454eaf3,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care,,Not Rated,19.05,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2
33.33,8f54b1ad-b8cd-44a3-94d7-c98133ca913d,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Unscheduled Care Data Mart,,Not Rated,19.05,a265af2e-40fc-4759-af61-eab293cdad5a
84.13,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,25.58,79.36,Bronze,1.1.7,25.4,75.31,The impact of hospitalised patients with COPD: from admission to outcome,HUB > PIONEER,Silver,76.19,780bf7d0-9ee1-4641-a74f-dc148e361970
33.33,8fc6bf25-df25-429f-be41-b7d5ffd4ff15,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Eye images and retinopathy grades in diabetic eye screening,,Not Rated,19.05,3b1bb176-e22f-402a-b863-730d05b22021
33.33,90ace555-da01-4940-a3ef-78bb83976ff0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 COG-UK Viral Genome (variant strain data),,Not Rated,19.05,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8
33.33,90db47a7-d082-4778-884c-78f9b6c7e57f,58.14,34.12,Not Rated,1.1.7,65.08,30.45,RAPID (Hospital Stay Level Data),,Not Rated,19.05,1fc57971-5af5-499e-a500-4ffbb087f0c4
33.33,90f44ae7-8394-4fe5-8c1e-c9aa5bf0edf1,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Prescribing Information System (PIS),,Not Rated,19.05,22e3943e-edb5-44a1-9e4e-22b0f7a31767
63.49,914321d0-1d86-4974-a38d-97469f9ff2cd,16.28,73.81,Silver,1.1.7,15.87,77.58,Bloodwise Childhood Leukaemia Cell Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,93baeb13-cc4b-47fd-9dae-5ae5277cba54
33.33,9147f060-0210-40a6-a557-ce744a63f912,51.16,41.27,Not Rated,1.1.7,50.79,33.95,"Demographic risk factors, biomarkers, physiology for Acute Compartment Syndrome",,Not Rated,19.05,60c1557a-4541-429f-bbe5-f9edbdb34f8a
23.81,91b2fdab-1d0e-41a1-a9cc-1ebb536c7ee5,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,ALLIANCE > HQIP,Not Rated,28.57,3afbb83d-d47b-43b3-a202-0d3081e5d294
52.38,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,23.26,64.28,Bronze,1.1.7,23.81,68.13,Seasonal Influenza Vaccine Effectiveness II,HUB > BREATHE,Not Rated,59.52,50b47298-d935-4990-a002-e26b6bb26d30
4.76,922f72c0-e3cb-4d89-a56f-50d938a87630,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"Estimate the cost of care, quality of life and wider societal burden due to COPD",,Not Rated,4.76,ee6013d6-5584-4275-b124-3113ee5ad37d
33.33,925feb2c-195f-460c-bae7-f17ea652fd5d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Revision Elbow Replacement dataset,,Not Rated,19.05,12babf2b-42e8-4b1e-9143-3475a07bb343
4.76,927beb63-f650-4972-a3ad-af8e29dc26a5,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Omega 3 Cohort,,Not Rated,4.76,a1bcea4c-89dd-4cdb-978c-43db676ed73c
96.83,931efe47-04eb-4ff3-aa62-97e2e4007aed,20.93,84.92,Silver,1.1.7,26.98,85.97,Yorkshire Specialist Register of Cancer in Children and Young People,HUB > DATA-CAN,Silver,92.86,93582beb-e45a-47b6-aeab-d26f583e4c3b
100.0,9360bc6c-2a7d-4415-869d-3e853c558f4d,18.6,88.89,Gold,1.1.7,22.22,88.32,National Survey for Wales,ALLIANCE > SAIL,Gold,95.24,bcca421a-9077-4c47-9daa-b1bc030d3dee
87.3,93aeac00-2e6d-44d7-8643-092c587c241a,25.58,79.37,Silver,1.1.7,28.57,77.69,South West Primary Care Dataset,HUB > DATA-CAN,Silver,80.95,a47a8c77-3ced-43a0-acf0-3997c4eb5a29
34.92,93d26255-7199-4ea7-997d-f74890d12b87,25.58,55.55,Not Rated,1.1.7,23.81,56.26,Imaging,UK Biobank,Not Rated,38.1,32a2dcb1-1e18-44ba-ad49-b3da312ca447
4.76,94188672-a44d-4ae3-8bb3-f249891a5af7,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,,Not Rated,4.76,64f78a5f-268f-4951-9c91-f7e7130baffa
60.32,9445e723-655a-43d0-a4e5-50313d98eac0,18.6,71.43,Bronze,1.1.7,17.46,75.22,National Unified Renal Translational Research Enterprise (NURTuRE),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,15f07cef-f4cc-4a50-90bc-9fd40f8b6327
33.33,94c7dca9-a96f-4e77-b156-96676a701834,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Covid Vaccination Dataset (CVVD),,Not Rated,19.05,471f101c-a45e-4620-8710-be3036a46fba
60.32,94e28efd-a976-4748-81fd-956a598c26cb,16.28,72.22,Silver,1.1.7,15.87,76.38,BioDock,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,ecb82441-286f-408d-880c-9239a25fb5cd
87.3,94f983ec-af41-451a-af5d-657ac58207c6,20.93,83.34,Silver,1.1.7,20.63,80.01,Unscheduled Care Datamart,ALLIANCE > PUBLIC HEALTH SCOTLAND,Silver,80.95,a265af2e-40fc-4759-af61-eab293cdad5a
63.49,94fab6d3-9753-4ffd-ade2-02d199d93f94,16.28,73.81,Silver,1.1.7,15.87,77.58,RAPPER,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,76d26f0f-0136-4ae5-8be9-37782a70bac5
33.33,953f6cc1-bd69-4fbc-a91b-d33f6c7aa6ca,51.16,41.27,Not Rated,1.1.7,50.79,33.95,GP dataset - Welsh Primary Care,,Not Rated,19.05,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2
88.89,9552365b-7b9a-4d04-a857-358d0e171424,32.56,76.98,Bronze,1.1.7,34.92,74.19,Pregnancy Register for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,14aaf184-5922-4459-affb-6c9e55c12176
4.76,95b26238-3379-4188-ad6c-a09657b77648,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"4 Country ChrOnic Respiratory Disease study: PILOT PHASE, Islamabad",,Not Rated,4.76,a6ea6185-2e2e-4738-b7f1-dc052eae902e
69.84,96c73136-da1b-43de-9fd1-9d5e63631b14,30.23,68.25,Not Rated,1.1.7,33.33,64.64,VIVALDI 2,OTHER > UNIVERSITY COLLEGE LONDON,Bronze,59.52,12f1ffbc-0ddd-4d6e-b126-2cccf6738658
33.33,9701af08-c7d5-423e-acba-2a7dbcd1e69e,55.81,36.5,Not Rated,1.1.7,60.32,31.62,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - England,,Not Rated,19.05,9a36f3f8-3b7e-4e61-8993-b9cc2734fcb8
90.48,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,23.26,83.34,Silver,1.1.7,23.81,80.03,SAIL Dementia e-Cohort,ALLIANCE > SAIL,Silver,83.33,f48b7c05-6a44-480c-84c6-4f7a684f29f8
4.76,97771ec7-2abb-4d6e-b630-77c61a5e314a,46.51,29.36,Not Rated,1.1.7,46.03,29.12,FFFAP -  National Hip Fracture Database Facilities Survey 2019,,Not Rated,4.76,025c9e8a-938b-4886-9e03-fcad90fe7157
33.33,977ca75e-32da-4e60-a2e5-2bdf534a5986,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,,Not Rated,19.05,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0
4.76,97a5f21e-c0a9-4a04-978b-9f054d7b6bcf,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"Resilience, Ethnicity & Adolescent Mental Health (REACH)",,Not Rated,4.76,0f754b8b-353e-4e8d-9ff0-03d5e0817e02
92.06,97ae3443-b60b-4b33-b861-83663caea1dc,30.23,80.16,Silver,1.1.7,31.75,77.74,HES Admitted Patient Care data for CPRD GOLD,ALLIANCE > CPRD,Silver,85.71,4bcf64a6-f404-4ef4-ae6e-172512ab5f43
77.78,97fa09e6-5ea5-41cd-baf8-20366db13a3f,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,eab996ed-b268-439a-bff4-19925698336a
33.33,9836e0e1-5ea2-4dc4-be5a-24e390b7fa33,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Characterisation of hospitalised COPD exacerbations using real world data,,Not Rated,19.05,f6f2978d-4a49-4dd9-8615-78d28e6dc83c
63.49,99812cec-ea1c-4979-8e00-32df5bad000b,18.6,73.02,Silver,1.1.7,17.46,77.61,RATHL Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,73.81,e5ec63dd-4da5-4119-99c8-5cc79045618c
33.33,99b505ee-44c6-497d-b30b-3ce80eba4047,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),,Not Rated,19.05,8e0221d4-dcfa-4580-834b-f44421fca3b5
88.89,9a5fdb85-7bd6-4073-9058-e45667d497a8,27.91,79.37,Silver,1.1.7,30.16,76.52,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),ALLIANCE > CPRD,Silver,80.95,61a607a9-b404-41e0-a52e-0c6d0ce8c2be
4.76,9a836aa8-60c7-4911-943e-477b0ae8bbb8,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Blended learning for primary care physicians on COPD in Bangladesh,,Not Rated,4.76,3907a55f-104b-4533-ba21-69bd5f08ce8f
33.33,9abb8804-de89-4aba-8877-0e9a405870fe,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Systemic Anti-Cancer Therapy Dataset [SACT],,Not Rated,19.05,6c4ed998-0f05-415c-a3e4-42430bb62d24
33.33,9b356432-2650-4ded-aa75-657871b38fe3,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Neovascular age related macular degeneration at University Hospitals Birmingham,,Not Rated,19.05,89c2c798-2e0f-4235-9cd9-e2347f2dfc50
23.81,9b7d2306-35e2-44a3-a97d-0b0e03a15336,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),ALLIANCE > HQIP,Not Rated,28.57,2b640175-725a-465f-9aec-6794e6d27791
46.03,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,32.56,57.94,Not Rated,1.1.7,30.16,57.53,Mental Health Services Data Set - Currencies,ALLIANCE > NHS DIGITAL,Not Rated,47.62,add485fa-4c54-4a3e-8676-abe2ff4725a5
85.71,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,27.91,77.78,Bronze,1.1.7,30.16,75.33,PHM and Cancer Outcomes in the WYH Cancer Alliance,HUB > DATA-CAN,Silver,78.57,bc839e9c-e303-4c3c-9c2c-9975602376e2
33.33,9c2356fe-409f-4a34-9fbf-663d2add3902,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Domiciliary Social Care Worker (DSCW),,Not Rated,19.05,0e38bbf4-c788-4a1a-9af8-a24821250154
33.33,9c31bd50-e999-4d4d-bb9d-545c00fcf23e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Optimum Patient Care Research Database (OPCRD),,Not Rated,19.05,ac755244-4143-4629-9170-a9e8fc98bb1e
100.0,9ca6e8d2-98d2-4757-84e1-287585400e55,18.6,88.89,Gold,1.1.7,22.22,88.32,"Extended Cohort for E-health, Environment and DNA (EXCEED)",HUB > BREATHE,Gold,95.24,e22ddf52-7f9e-4072-ae61-cb722461b37d
33.33,9cb83fb7-e8d7-436b-b847-e4759b9589c5,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Survey for Wales Dataset (NSWD),,Not Rated,19.05,bcca421a-9077-4c47-9daa-b1bc030d3dee
33.33,9cc82b97-d508-4cb9-98ca-0105aa897bb6,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK Renal Registry - Kidney PREM dataset,,Not Rated,19.05,ea068fd4-1a96-4ed5-a010-8930afb968bb
95.24,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,20.93,85.72,Silver,1.1.7,23.81,84.78,IBD NIHR BioResource: Sample holding,HUB > GUT REACTION,Silver,90.48,f2af20f9-af84-40ce-8a07-7d095948653e
33.33,9da5acec-1749-46a6-bf93-51457bbaa52c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,,Not Rated,19.05,fbe1ae63-0c12-48e5-be16-87d6bc7bd179
44.44,9de20d42-8e9b-45c8-8574-52a49fba826c,25.58,59.52,Not Rated,1.1.7,25.4,63.4,Respiratory social media database,HUB > BREATHE,Not Rated,52.38,43fc768a-9d2c-4c6d-952f-d8570c487b4a
100.0,9e67001e-7c77-4bc0-9af2-5138b5d638e4,16.28,89.69,Gold,1.1.7,20.63,89.48,Annual District Death Daily,ALLIANCE > SAIL,Gold,95.24,584bf8c8-d58f-44c6-9b65-e1611144fd54
33.33,9ea7a624-ce4c-460e-b68f-0655dac36765,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Radiotherapy Dataset (RTDS),,Not Rated,19.05,f102ca50-d1e4-44ec-924e-be89446652af
87.3,9f7608a0-2424-457d-ba50-f51a4444403b,27.91,80.16,Bronze,1.1.7,26.98,75.33,Patient postcode linked deprivation measures for CPRD GOLD,ALLIANCE > CPRD,Silver,78.57,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb
33.33,9fe99176-1cbf-41f7-901d-245051dbe410,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Granular ICU data focussing on the impact of lactate readings on outcomes,,Not Rated,19.05,edfc20b7-5a5e-40c4-afd0-a7a5bba77003
33.33,a0292641-9e1a-495d-a7f2-d9ce87ff0b88,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Outpatient Referral (OPRD),,Not Rated,19.05,7465c65e-c321-42e9-a2f4-6bc664caf1fc
33.33,a03b66c6-f56d-40f8-bb9b-06751d97864c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Revision Shoulder Replacement dataset,,Not Rated,19.05,9623e62b-3c50-44aa-8923-0bbb94e7ad61
33.33,a04b16f3-dd24-47de-8c20-699b88eb4da0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Neonatal Research Database (NNRD),,Not Rated,19.05,67020745-9def-4c6e-b5ac-bb273bd0a20e
60.32,a06afa88-caba-4354-ac70-d05c67b34dfc,16.28,72.22,Silver,1.1.7,15.87,76.38,UK CLL Trials Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,636e216a-072b-4c8b-b867-23b7666d2cb2
98.41,a0e0c0c2-072a-47ac-9252-e27b37ac024f,37.21,78.57,Silver,1.1.7,41.27,77.83,HIC Transplantation,NIHR Health Informatics Collaborative Renal Transplantation Theme,Silver,92.86,359a322e-3781-4796-b6b2-81962fa19b7a
87.3,a1164dbd-4057-45a2-9860-cbb69696bd7c,27.91,78.57,Silver,1.1.7,30.16,76.52,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,2439a88e-d961-4152-a7b5-042097946209
34.92,a11a234b-8b59-41e8-920a-f8f1799d3c77,25.58,55.55,Not Rated,1.1.7,23.81,56.26,Biological sample assays,UK Biobank,Not Rated,38.1,14c697a5-2d41-4d86-bf17-2e596d07418b
77.78,a1a67182-e81b-4144-ac51-92a86f277eb2,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,7b31b427-b447-432e-9a6c-ad2099343491
23.81,a1d41f64-76e1-4576-a906-f64a7fe664c4,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,ALLIANCE > HQIP,Not Rated,28.57,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f
100.0,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,13.95,92.06,Gold,1.1.7,15.87,90.64,Brecon dataset,ALLIANCE > SAIL,Gold,95.24,9c6e891f-6449-48d2-a1c3-8dd236e34bbd
33.33,a2226588-3fce-4103-8960-6bb0b22631fb,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Cafcass England (CAFE),,Not Rated,19.05,8ee61578-e298-423a-be22-cb0438023e5c
33.33,a25181ec-a00c-4031-9f35-5cb072477e64,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma & COPD Audit:COPD and adult asthma organisational dataset,,Not Rated,19.05,1982d9ef-890a-41ff-a86a-de61d65aaa09
33.33,a2a324f8-ccd3-405b-a146-34bbb85cc34a,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Enhanced Prescribing Database,,Not Rated,19.05,2843087f-23a4-4cfe-8e72-53f2b9562cc3
100.0,a337845e-1dde-445b-90cf-91d8b825e3a5,20.93,86.51,Gold,1.1.7,26.98,87.16,Comprehensive Patient Records for Cancer Outcomes,HUB > DATA-CAN,Gold,95.24,ce4582a8-0985-46c6-b95f-29a5de862d4a
4.76,a41cfa11-ee7f-4ebe-be2a-f1235e34951d,46.51,29.36,Not Rated,1.1.7,46.03,29.12,"Peer-led, Professionals Assisted Pulmonary Rehabilitation (PLPAPR): pilot study",,Not Rated,4.76,dec5d8da-2d63-4ab8-927e-4a5a659dc541
100.0,a45acd02-82d7-4bfe-9845-6b4df683bba8,13.95,92.06,Gold,1.1.7,15.87,90.64,Care Home Dataset,ALLIANCE > SAIL,Gold,95.24,aae02f9e-1bad-415d-9730-c46a07a990aa
33.33,a4936ec2-002e-4927-9a46-29ae9b5d695f,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Demographic,,Not Rated,19.05,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1
80.95,a4eb97a6-6a61-415b-9dfb-65503675ed00,23.26,77.78,Silver,1.1.7,25.4,76.47,Health & Attainment of Pupils in a Primary Education Network [HAPN],ALLIANCE > SAIL,Silver,76.19,464d8653-4e69-406b-93fd-d68c29d5dfdc
23.81,a513dd3b-7e58-4d7f-8164-0a4dbe0a96c0,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Paediatric Intensive Care Audit Network - core dataset (referral),ALLIANCE > HQIP,Not Rated,28.57,79ae4881-6223-471a-a278-6b2d3b84f971
63.49,a5163bce-7c03-4e61-8ebc-024939c047a8,16.28,73.81,Silver,1.1.7,15.87,77.58,UK ME/CFS Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,d0694e15-b6ba-4a95-962a-dbf627ca207c
85.71,a53b2f7a-c4a6-4914-9adb-17946c58afad,30.23,78.57,Bronze,1.1.7,28.57,72.98,Rural-Urban classification for CPRD GOLD,ALLIANCE > CPRD,Silver,76.19,a7d8c6a8-0825-4e73-8f29-3d76194d7114
33.33,a5a4a55c-c311-445d-a21f-0e4acb42f227,55.81,36.5,Not Rated,1.1.7,60.32,31.62,ISARIC4C COVID-19 Clinical Information Network (CO-CIN),,Not Rated,19.05,84336be3-23bd-466e-b29b-df48db897665
4.76,a5b41636-a112-4631-aaee-215bc4cf200e,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,,Not Rated,4.76,95f385b1-4f5c-4a88-8e79-9613acc66938
23.81,a5c088cd-dae6-4c58-b381-a0d273585f4d,34.88,44.45,Not Rated,1.1.7,34.92,46.84,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,Not Rated,28.57,d472a895-8587-4503-956e-3bd66d990979
33.33,a5d1a44f-9e9d-4c6d-9ce0-53889d579781,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Patient Medical Card Registration (NI),,Not Rated,19.05,4e5ba567-c452-4979-8e2e-865f7df20252
33.33,a6252de5-4fc3-4dc7-950b-2f2528f58533,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Scottish Stillbirth and Infant Death Survey,,Not Rated,19.05,e54d35a6-2e7c-422d-a4a5-a7da930b08f2
60.32,a6472a29-17db-477c-bb6e-264686c8fc26,18.6,71.43,Bronze,1.1.7,17.46,75.22,plasmaMATCH,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6
33.33,a69493b6-991d-40b5-ba81-2f70c424c557,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Child Health Systems Programme - First Visit,,Not Rated,19.05,dec04153-f595-41ce-9d7e-5ef0c3fe8289
4.76,a7447f01-c3fd-43f1-8fc4-3e6f3b6e59ef,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Records of Scotland (NRS) - Births Data,,Not Rated,4.76,3b87eef0-bfb6-4bf4-84b9-29880197fec9
14.29,a74f72ad-bf70-42e4-8933-069c7b53c7f9,37.21,38.89,Not Rated,1.1.7,36.51,39.73,LIMS,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,df70b490-3c00-458e-a6dd-ea3242a3ebac
87.3,a79944dc-2696-4326-b378-dbd9224635f1,27.91,78.57,Silver,1.1.7,30.16,76.52,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,ALLIANCE > CPRD,Silver,80.95,7958450d-bd25-42c4-b79e-0e3d0806ac21
4.76,a8364fd6-2247-4ef0-af8c-51c7b3ec24cd,46.51,29.36,Not Rated,1.1.7,46.03,29.12,The 1970 British Cohort Study (BCS70),,Not Rated,4.76,929186f3-e230-4b52-a9f5-0c20af7f5ce2
4.76,a889651d-a26e-4907-86a3-a06d100d13f5,46.51,29.36,Not Rated,1.1.7,46.03,29.12,NIHR BioResource: NHS Trust data,,Not Rated,4.76,3731006a-ee7c-4d15-bc07-4eeb29a3d031
98.41,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,16.28,90.47,Gold,1.1.7,17.46,88.29,Healthcare Workers Risk Assessment,ALLIANCE > SAIL,Gold,92.86,ed131fee-0635-4613-a453-a383d5dd7cec
23.81,a8bfd0c4-1aec-47cc-9e45-00a713482fa2,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Paediatric Intensive Care Audit Network - core dataset (transport),ALLIANCE > HQIP,Not Rated,28.57,45310176-6331-4bdd-bc53-d9194e212a35
4.76,a8c8978f-b5dc-448c-9a03-4d961d79a863,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Scottish Immunisation Recall System (SIRS),,Not Rated,4.76,c027d0ca-7c7d-4864-b4dd-8040f4020fbb
55.56,a8f5117e-7523-452f-abf3-ced72f03cb2e,18.6,68.25,Bronze,1.1.7,19.05,71.65,Salford Lung Study,HUB > BREATHE,Bronze,61.9,86838cad-d5d3-4b65-9c37-29b0c8c36309
82.54,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,25.58,78.57,Bronze,1.1.7,25.4,74.12,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",HUB > PIONEER,Silver,73.81,ddf7f82f-b453-442d-b562-bb0157593831
96.83,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London Primary Care Events Data (NWL PCE),HUB > DISCOVER NOW,Gold,92.86,0f930154-0a0e-4bef-9464-59e657b904d6
77.78,aa019da2-0f2f-493c-95e8-7263ee735f46,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),ALLIANCE > NHS DIGITAL,Not Rated,64.29,348b12fb-7718-477e-a572-4fc3c716152d
88.89,aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,25.58,78.57,Silver,1.1.7,31.75,77.69,ONS 2011 Census Wales (CENW),ALLIANCE > SAIL,Silver,80.95,fc24482c-0f9b-445f-af7a-8598627c3b15
33.33,aa25e5e4-9d53-4f7b-a7fb-228835f6bfd8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Death Registration Data - Provisional Monthly Extracts,,Not Rated,19.05,487222b7-5c13-4a92-8b41-044796048720
33.33,aabb918b-b15f-4c1e-a50a-8ceee6993d70,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Critical Care Dataset (CCDS),,Not Rated,19.05,1789286a-deaf-49df-88cd-660e92934af6
4.76,aad2340a-ab87-40ee-bfbe-c56adb01fd47,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,,Not Rated,4.76,bfa012ad-e609-4d15-a824-6d143758ca4d
33.33,ab0f56e2-681f-4e43-b798-94685ddc3c4a,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Weekly SUS ECDS Dataset,,Not Rated,19.05,f75b02f0-a45f-433a-a669-420c8bd40720
4.76,ab2dafd8-b513-4b33-9365-5eb74f32f9d1,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Developing Patient and Public Involvement in Research in Malaysia,,Not Rated,4.76,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc
4.76,ab7f482c-42ea-4ddb-8c92-5ecc1be868ce,46.51,29.36,Not Rated,1.1.7,46.03,29.12,GOAL,,Not Rated,4.76,563c0bfc-437e-4c10-b144-b392d983017c
33.33,ac057e24-22d8-478e-8988-89fe4ee67b6c,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Walker Study Data,,Not Rated,19.05,245bffa9-07c3-40b6-916b-161062cdf674
33.33,ac7927ca-ef8b-47d7-abce-33a03baaac5c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Tayside Bowel Screening Dataset,,Not Rated,19.05,00201dde-1faf-41d3-b282-5c24c0ca3697
74.6,acafb160-b18a-436e-90f1-dc4530a90267,39.53,67.46,Not Rated,1.1.7,39.68,61.19,Mental Health Minimum Data Set,ALLIANCE > NHS DIGITAL,Bronze,61.9,285ae0ae-196b-4a75-b1f1-78b07162acfa
84.13,ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,25.58,77.78,Bronze,1.1.7,28.57,75.31,COVID-19 SARI-Watch (formerly CHESS),ALLIANCE > NHS DIGITAL,Silver,76.19,f61f116d-f732-450e-9d34-c6ae00e3fd1e
33.33,ad5dd22c-f6e1-4338-9d4e-80e4b9ec8f26,51.16,41.27,Not Rated,1.1.7,50.79,33.95,2019 UK Parkinson's Audit - Elderly care and neurology,,Not Rated,19.05,0cac3870-dd13-44fc-97c2-4bdb67550b39
92.06,ad638da8-366b-481f-995e-fc326301eb16,20.93,84.12,Silver,1.1.7,23.81,83.58,IBD NIHR BioResource: Contact detail,HUB > GUT REACTION,Silver,88.1,02ddc5c9-03d4-40e4-9934-e60817ec8f3e
60.32,adbee090-9634-455e-9be1-62843158fb08,16.28,72.22,Silver,1.1.7,15.87,76.38,Cardiff School of Dentistry Tooth Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,0d4f0103-82d8-43f4-8058-4aec80ea562f
96.83,adce90ad-d576-4c98-9de9-dca19f7f4d41,18.6,87.31,Gold,1.1.7,22.22,87.13,North West London Admitted Patient Care Data (NWL APC),HUB > DISCOVER NOW,Gold,92.86,788857b5-6a5b-4ec2-825e-d965e291cf45
60.32,ae2022bc-2083-4e57-b825-1fb610d910ee,16.28,72.22,Silver,1.1.7,15.87,76.38,Biobank for patients with retinal degenerations & dystrophies,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,cee932f8-151c-4834-ac6d-61d842f9d170
33.33,ae68c3c8-7930-40bd-86e8-7ca1aa6ce57d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID antigen testing - Pillar 2,,Not Rated,19.05,c8f2ee14-2831-445d-a207-2f7f932f4735
100.0,ae788191-69e5-4a03-b11b-bd25574b0e4f,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient NTM culture,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b
15.87,ae9e8a9f-533f-4823-8e00-84e39ad2c266,39.53,38.88,Not Rated,1.1.7,38.1,39.76,Community Services Dataset,ALLIANCE > BARTS HEALTH,Not Rated,19.05,cae0a9a5-1bf2-49c3-b8d1-c315d3239074
50.79,aecc1328-3c30-4eff-9f56-ae1278846ef9,20.93,65.08,Bronze,1.1.7,20.63,68.1,Accelerometer,ALLIANCE > UK BIOBANK,Not Rated,57.14,ceab57e8-1e13-499b-a8f4-6ad60dad3721
63.49,af2b3e6d-718e-464a-8c0d-5882fa1d869f,16.28,73.81,Silver,1.1.7,15.87,77.58,Manchester Cancer Research Centre (MCRC) Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,095d805c-4b62-4726-b968-bb2f1c463701
63.49,af2ecff2-398c-437f-8c45-adef2406ce43,16.28,73.81,Silver,1.1.7,15.87,77.58,Cardiff University Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,097540aa-a0ed-492e-853b-9ebcfd061dea
60.32,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,16.28,72.22,Silver,1.1.7,15.87,76.38,NIHR Exeter Clinical Research Facility,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,df9b7bb1-1b26-4e67-b885-df2dcb8e3450
33.33,af6db86a-b901-442e-adf5-f29f6c1dc16e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Ambulance Services NHS Trust (WAST) - Legacy,,Not Rated,19.05,d415a5c5-8432-4a81-937f-12135ade6de7
33.33,afc74c32-efdf-4aab-a0bb-fe5586f4af78,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Audit of Care at the End of Life - organisational level audit,,Not Rated,19.05,a290592c-a6f5-4874-b283-1d33e923c487
4.76,b009b68f-730a-4d72-9a3c-c917b1ff715d,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Childhood Pneumonia Governance in Bangladesh,,Not Rated,4.76,5df03d24-ad95-4d64-96df-0684a4f26e58
87.3,b02e2091-f48a-4d50-91a0-de8c76f76c18,27.91,78.57,Silver,1.1.7,30.16,76.52,HES Diagnostic Imaging Dataset for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10
33.33,b0319b9b-14ba-4e23-86ff-89363d4d69a7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID antigen testing - Pillar 1,,Not Rated,19.05,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec
33.33,b04e89c3-3c56-4ad9-b929-d3937874df52,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Emergency Care Dataset (ECDS),,Not Rated,19.05,57fa56f2-78d1-49af-ab8d-e8146d711868
33.33,b05cb16b-80dc-4e16-8d86-8ee741a5e051,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Audit of Care at the End of Life - case note review,,Not Rated,19.05,d8c67899-2d81-48c2-8482-31cd33973a36
33.33,b07485ca-2d45-483d-9336-32cca4504712,55.81,36.5,Not Rated,1.1.7,60.32,31.62,SICSAG Episodes (Scottish Intensive Care Audit Group),,Not Rated,19.05,6f8182d2-2993-400d-829d-b52cdb324bf3
33.33,b132812c-7a5c-4d2d-aca2-fdcdb890283a,51.16,41.27,Not Rated,1.1.7,50.79,33.95,HIV-POGO,,Not Rated,19.05,e171a080-a4cd-4e64-9c2b-e72beb7cac78
34.92,b27afede-a51d-4aae-8bf7-ce94888fe898,25.58,55.55,Not Rated,1.1.7,23.81,56.26,Primary-care data,UK Biobank,Not Rated,38.1,439e71c7-33b5-4e85-98ce-4b068f2523ad
4.76,b2f48da1-d3c6-4126-a74b-e87c2f629ef8,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Lothian Birth Cohort 1936 (LBC1936),,Not Rated,4.76,e63613a9-92e9-4147-8a76-40e4a87ec131
100.0,b2fb79c5-26db-484b-8e93-1c56d7654f57,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Transplants,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,bea354e8-c552-41ef-80c2-a76ca5767e4b
33.33,b3004f9b-11a0-482b-9cec-791b28fd492e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Fife Microbiology: Tests,,Not Rated,19.05,0c43c0b6-de3a-478b-8190-4da37fbe5ff5
100.0,b40777a2-468b-4b45-8b7d-2f62f912e950,34.88,80.16,Silver,1.1.7,39.68,80.18,HIC ICU 8.3.2,NIHR Health Informatics Collaborative Critical Care Theme,Silver,95.24,4f546f1e-433c-4884-a090-2a4520c878ac
33.33,b41215cd-afe1-4463-9786-ed86812143e2,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CPRD GOLD,,Not Rated,19.05,a29feafa-7bdd-44e9-b977-c9d26425e67f
88.89,b43309eb-7860-49b7-9f11-1a7a0fd5532e,25.58,78.57,Silver,1.1.7,31.75,77.69,UK Cystic Fibrosis Registry (CYFI),ALLIANCE > SAIL,Silver,80.95,0628fb77-057d-4838-b80e-18245a8f535d
100.0,b5033be2-0744-49c5-a398-a4d3ed4e1deb,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Chronic Medication,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,0ad31772-0893-4cf7-bab0-683e80302201
74.6,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,44.19,62.69,Not Rated,1.1.7,49.21,58.86,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,61.9,ef22c16c-c294-46e1-abf9-5204212e9053
90.48,b589b19b-b43f-4344-affb-5d7ea328c909,25.58,82.54,Silver,1.1.7,25.4,78.88,Radiotherapy Dataset,ALLIANCE > SAIL,Silver,83.33,f102ca50-d1e4-44ec-924e-be89446652af
33.33,b63aadf4-da85-478e-a171-05714ef9057e,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry - Lower Limb Angioplasty clinical dataset,,Not Rated,19.05,c8b6c319-239b-4792-9898-644a63d07ab5
4.76,b670cfe7-d4e2-46e5-b3e9-dccfd05c02d2,46.51,29.36,Not Rated,1.1.7,46.03,29.12,DataLoch Core,,Not Rated,4.76,d62939c4-e4a8-4fca-91ed-54f7f87fb89e
58.73,b6a60be1-5d94-41f9-a426-5f9523a98d50,18.6,69.84,Bronze,1.1.7,19.05,75.22,Development of spirometry predictive values for Indian population,HUB > BREATHE,Bronze,69.05,59521b01-6adb-4dd3-8b40-dbeb51171e4f
33.33,b6f26b11-da8d-402a-91c7-3b7122be274c,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Demographic Service (WDSD),,Not Rated,19.05,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d
33.33,b6fe3b50-aff3-435d-9c57-8b46eaa34671,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Welsh Longitudinal GP Dataset - Welsh Primary Care (WLGP),,Not Rated,19.05,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2
100.0,b70900e9-85e9-4dd2-ae4b-02523be4219d,13.95,92.06,Gold,1.1.7,15.87,90.64,Cafcass England,ALLIANCE > SAIL,Gold,95.24,8ee61578-e298-423a-be22-cb0438023e5c
33.33,b789c975-7042-445c-bfa6-c24e5ca8a983,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UHB 100K Genomics patient clinical data including their acute care contacts,,Not Rated,19.05,ceae4fe0-4e98-4e3c-85db-e86539aade81
60.32,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,16.28,72.22,Silver,1.1.7,15.87,76.38,Public Health England Seroepidemiology Unit,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,89497432-17e0-49f4-96a4-65ef57d07701
4.76,b95a3ebd-f1f2-4f5f-a598-1eaa60dd1790,46.51,29.36,Not Rated,1.1.7,46.03,29.12,COVID-19 Detection from Chest X-Rays using Deep Learning,,Not Rated,4.76,57526718-0a9a-42ad-8b7a-582d9ef96d13
60.32,b9642fb3-3bee-491b-8d83-22f9de0fd77f,18.6,71.43,Bronze,1.1.7,17.46,75.22,ESPAC-TPlus,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,47f979bc-da9d-4e9e-9f2b-15e09366db04
33.33,b97ff350-f84d-4739-a4d6-f3a607063799,53.49,38.88,Not Rated,1.1.7,55.56,32.78,2019 UK Parkinson's Audit - Patient Reported Experience Measure (PREM),,Not Rated,19.05,6a6c4568-59e9-4760-89d6-07558a24944c
33.33,b988b8bc-fbc5-40a7-8123-76ea5286b8c7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,,Not Rated,19.05,0d556d7e-be27-4979-a09e-d419b2e838f3
23.81,b9b4ee9a-3ffa-483d-8e46-16f862c83740,32.56,45.24,Not Rated,1.1.7,33.33,48.0,Paediatric Intensive Care Audit Network - customised data collection,ALLIANCE > HQIP,Not Rated,28.57,6c78af2c-3898-435e-b1f4-e6a44682dc71
4.76,b9ffcd6b-cabd-4875-ac5c-5cb878f7290f,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Pneumonia case management practices in selected communities in Pakistan,,Not Rated,4.76,cf190350-74c6-45f2-8ede-69ace62eb88d
77.78,ba071b0b-5ef4-457b-b194-3a69c2c71a06,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,3adeb2f4-a924-49cb-9537-84a9a4242a62
33.33,ba0bf718-05ab-4a6c-9419-1d04991d9ee9,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Primary Elbow Replacement dataset,,Not Rated,19.05,b06415af-9151-4ccc-83a1-ab859943fb2b
33.33,ba30a8b6-bfc7-4105-b094-11f187c7b293,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Emergency Department (Symphony),,Not Rated,19.05,8002b4d7-ff3b-4402-b805-a6a0022836fd
33.33,ba936454-e65e-491d-a16d-79115a4da09a,55.81,36.5,Not Rated,1.1.7,60.32,31.62,BathTAP Updating Cohort 1,,Not Rated,19.05,90131a34-3cc8-4a74-b72f-d9600cfa2808
33.33,bac86432-1ad7-4ff9-903d-26e28bf4ef97,51.16,41.27,Not Rated,1.1.7,50.79,33.95,CPRD Aurum,,Not Rated,19.05,1d574c14-1af0-490d-9c4e-be88cfd0e345
33.33,bb04212f-0626-4cbe-8863-a2cc1df40683,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID-19 Symptom Tracker Dataset (CVST),,Not Rated,19.05,594cfe55-96e3-45ff-874c-2c0006eeb881
33.33,bb61567b-431f-4e30-b906-654490ea14c7,53.49,38.88,Not Rated,1.1.7,55.56,32.78,IBD NIHR BioResource: Case report form,,Not Rated,19.05,877a7275-b99d-4ed4-9691-de577e0ab49e
33.33,bb833f51-bc38-4489-b693-6658ea772393,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CDE Clinical Events,,Not Rated,19.05,e3b36044-e1fb-418b-946a-b83626bf2e3f
33.33,bbd0a590-f4ee-4133-abe0-696cb247b3e0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Labour Force Survey (Longitudinal),,Not Rated,19.05,4ac15572-fe9a-46d3-860d-a46b616181f7
4.76,bbed7a4e-0c38-48b8-b4f8-b617ec307f59,46.51,29.36,Not Rated,1.1.7,46.03,29.12,1958 National Child Development Study (NCDS),,Not Rated,4.76,0ceaaedc-4904-4820-8b74-d6a8e679fb11
23.81,bc236fba-2935-4406-aaa9-0006cbbf693d,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),ALLIANCE > HQIP,Not Rated,28.57,ac7016ce-f7a9-4c71-bebb-6af6efa27844
36.51,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,23.26,57.14,Not Rated,1.1.7,22.22,58.61,UK Biobank Assessment Centre,UK Biobank,Not Rated,40.48,2775b97f-1606-490e-81ef-35bad050434a
90.48,bd87cdf4-ec39-41f6-bb07-c19f10372840,23.26,81.75,Silver,1.1.7,26.98,80.03,Education Daily Attendance Dataset,ALLIANCE > SAIL,Silver,83.33,17056e83-ee5a-4fe7-86e1-f09563256be1
88.89,bd90290d-d60b-499f-b30d-88332274cc46,25.58,81.75,Silver,1.1.7,25.4,77.69,Cancer Patient Experience Survey (CPES) for CPRD GOLD,ALLIANCE > CPRD,Silver,80.95,a4ecb8df-c72f-4018-8f23-e180c28dfdb6
77.78,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,3d348613-2d66-4814-a294-7e0c365f43f8
68.25,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,27.91,68.25,Not Rated,1.1.7,31.75,65.81,Oxford Healthcare Workers,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,Bronze,59.52,9de2f365-4c5d-4252-acee-6270b113aa93
60.32,be77a483-2eff-4c05-8091-035fe79b3c8a,18.6,70.64,Bronze,1.1.7,19.05,75.22,Barts CTU,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,22aa219f-f3c8-4a25-822e-aa2504f6f29a
33.33,be8ec01c-20ea-4863-ba7c-6d103df85a42,55.81,36.5,Not Rated,1.1.7,60.32,31.62,2011 Census - COVID19 Research Database Subset,,Not Rated,19.05,a05aef07-c3fa-4331-905a-6b6f58eac3d5
34.92,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,23.26,56.35,Not Rated,1.1.7,22.22,57.42,Online questionnaires,UK Biobank,Not Rated,38.1,8ef26f38-d1b3-4b24-b80a-717f216c6aea
14.29,bf83ada4-b72e-4789-b177-12a53aa763ea,39.53,38.09,Not Rated,1.1.7,38.1,38.57,TheatreEvents,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,2c6adf80-f30b-46c9-b9d4-fe3e68622469
33.33,bfbd3c63-8902-4242-97d5-ca935591e8cb,55.81,36.5,Not Rated,1.1.7,60.32,31.62,EU Farm Structure Survey Wales (EUFS),,Not Rated,19.05,cc7aa34f-81df-42f8-ad69-80e136c48bf1
33.33,c01fbdae-33e3-4839-b842-3b61a722a925,53.49,38.88,Not Rated,1.1.7,55.56,32.78,"Ventilatory strategies, medications and outcomes for patients with COVID",,Not Rated,19.05,55a744c4-a2d4-4ea0-b0eb-1af6e1465383
63.49,c03468f4-ba51-4d9f-a785-f041adb84724,18.6,73.02,Silver,1.1.7,17.46,76.42,Daisy Tumour Bank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,b3ec5c18-e339-4bd8-8a59-5a3445a81f16
100.0,c1682cb7-8f43-49fa-b66a-0a4a205885d3,18.6,87.3,Gold,1.1.7,25.4,88.32,Cystic Fibrosis Patient Demographics,ALLIANCE > CYSTIC FIBROSIS TRUST,Gold,95.24,19bc55c2-13d7-4488-a52c-35287483ea4e
33.33,c230a8d8-bf78-4713-8f2f-312162e92e55,53.49,38.88,Not Rated,1.1.7,55.56,32.78,COVID-19 Vaccination Status,,Not Rated,19.05,98372a87-f3e6-475d-be12-46c0f9587413
60.32,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,18.6,71.43,Bronze,1.1.7,17.46,75.22,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,ba0edcaf-854d-4907-851a-280b56128b3b
100.0,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,16.28,89.69,Gold,1.1.7,20.63,89.48,Outpatient Referral,ALLIANCE > SAIL,Gold,95.24,7465c65e-c321-42e9-a2f4-6bc664caf1fc
87.3,c2e112a0-a198-46b0-9a0c-ec91edfb6839,25.58,80.16,Silver,1.1.7,26.98,77.69,National Diabetes Audit,ALLIANCE > NHS DIGITAL,Silver,80.95,9a434a5c-563b-4da1-9133-9994960ade54
33.33,c303bdc0-fa5d-4c22-84ca-83577446062d,58.14,34.12,Not Rated,1.1.7,65.08,30.45,Covid Lateral Flow Test (CVLF),,Not Rated,19.05,ce60d677-6263-4d41-9d45-d3c7ebb3ee36
63.49,c3b4f4f2-953e-4470-bedd-9d09fd30a508,18.6,73.02,Silver,1.1.7,17.46,76.42,TRICON8,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,85113a93-89ed-40e3-a479-33b461b91858
87.3,c4426ec2-fbf0-45b2-9f68-0477527257a0,27.91,76.98,Bronze,1.1.7,33.33,75.33,2011 Census variables (and variable breakdowns),ALLIANCE > PUBLIC HEALTH SCOTLAND,Silver,78.57,a05aef07-c3fa-4331-905a-6b6f58eac3d5
33.33,c474492c-1c9d-4e94-bc85-270aab69a74d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Diagnostic and Therapy Services Waiting Times (DATW),,Not Rated,19.05,97896866-ab5e-408a-ac5a-072802db9faf
33.33,c47f463f-6e7e-4abb-b9bc-010ae68156b7,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Waiting List Open Pathways,,Not Rated,19.05,c7b1e328-f2d7-4d11-b38f-ce9930b95ca0
66.67,c66f943f-4307-4486-817c-49f6d8b9fd6b,30.23,65.08,Not Rated,1.1.7,36.51,63.45,PANTHER study,ALLIANCE > UNIVERSITY OF NOTTINGHAM,Not Rated,57.14,596077a9-298b-44cc-aa7a-81f04cf5dcb3
33.33,c6859b1b-4d5b-46bd-8532-089cff743be7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Child Health Systems Programme - 4-5 year review,,Not Rated,19.05,5844bde6-628d-4e76-bb56-3534e2728eb6
47.62,c6e2fffb-4817-462e-ba7e-ff546728f3d1,25.58,61.11,Not Rated,1.1.7,25.4,64.59,Exogenous sex steroid hormones and asthma in females of reproductive age,HUB > BREATHE,Not Rated,54.76,bc5d6d69-ec03-42fe-a63b-638c25c5258c
77.78,c713773c-e961-400e-b44a-947002deb073,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,ALLIANCE > NHS DIGITAL,Not Rated,64.29,334afc50-a05a-43b9-aa1e-a012a22733e0
66.67,c78122ae-8be1-40d7-8567-b83059941c16,20.93,73.81,Silver,1.1.7,19.05,77.63,SCOT translational sample collection,ALLIANCE > TISSUE DIRECTORY,Bronze,76.19,b3b790a7-a455-4efb-9c68-60e7131cb836
33.33,c8654ef8-585c-4ac4-ac0e-33a875d407a1,51.16,41.27,Not Rated,1.1.7,50.79,33.95,UHB Linked Diabetic Eye Disease in Acute Diabetic Hospital Admissions,,Not Rated,19.05,865c99c4-bbe9-45de-83b9-290fb54d5470
33.33,c8db5528-7ba5-40fe-8c5f-2c86a9637c73,53.49,38.88,Not Rated,1.1.7,55.56,32.78,CPRD Cardiovascular Disease Synthetic Dataset,,Not Rated,19.05,780c0a71-0264-4843-939d-1336eee60d40
33.33,c8edcbd8-40e6-4c34-b138-307a94c19cc0,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Admissions and Discharges,,Not Rated,19.05,1d5b9205-dae4-4b0e-a3d3-04707875edf8
33.33,c9322345-9fe2-404e-8dcb-0b4d8856459b,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Emergency Department Dataset Daily (EDDD),,Not Rated,19.05,fa257aa8-51fc-4eb7-a448-e473fa54686d
33.33,c93ff611-458c-4fc8-bb94-5274988f7f7f,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Annual District Death Extract (ADDE),,Not Rated,19.05,15cf4241-abad-4dcc-95b0-8cd7c02be999
60.32,c960ffab-a94c-45e3-96a0-598719acfbf5,16.28,72.22,Silver,1.1.7,15.87,76.38,National Diet and Nutrition Survey (NDNS),ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,f86400cb-7cab-4e34-aab6-57138b6a96c2
77.78,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,01c88a30-b14d-401e-82bb-165cbde81942
33.33,c9809e56-5b29-4ab4-a5f3-f72a2d6419fc,51.16,41.27,Not Rated,1.1.7,50.79,33.95,COVID-19 Test Results (PATD),,Not Rated,19.05,f5f6d882-163d-4ef1-a53e-000fba409480
80.95,ca05a688-c305-4ebd-967f-facb010c29bf,27.91,76.98,Bronze,1.1.7,26.98,72.95,Secondary Uses Services Payment By Results,ALLIANCE > NHS DIGITAL,Silver,73.81,2004c512-f7c9-4995-b820-55f36aa3fad2
100.0,ca2c6ec0-00ce-42fc-a077-88911259576c,18.6,87.3,Gold,1.1.7,25.4,88.32,Cystic Fibrosis Patient Annual Review Encounters,ALLIANCE > CYSTIC FIBROSIS TRUST,Gold,95.24,11360490-8da3-4a25-bb87-4fcc249b9af5
33.33,ca8c912d-82c4-481e-b17a-b567e3bf3c72,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Haematology (Lab Data Restructured),,Not Rated,19.05,c294bb01-062b-494e-942b-1efe8cbac3dc
100.0,caa644b6-a50d-455b-bee1-96232443e2b9,20.93,84.92,Gold,1.1.7,30.16,87.16,Cystic Fibrosis Patient Liver Enzyme,ALLIANCE > CYSTIC FIBROSIS TRUST,Silver,95.24,f72e80fc-dcd3-4457-ae91-dd14449002dd
4.76,caab69a0-b560-4320-ac61-557f81f37ae3,46.51,29.36,Not Rated,1.1.7,46.03,29.12,The Million Women Study,,Not Rated,4.76,97ac8a7d-30b9-4fa6-84db-b4f9430fc1d6
33.33,cace4854-a8de-4487-9c43-fe580b341d26,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Northern Ireland Regional Maternity system (NIMATS),,Not Rated,19.05,be7efa4f-e500-4a54-8157-6c4442a7e8a8
63.49,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,18.6,72.22,Silver,1.1.7,19.05,76.42,UKCTOCS Longitudinal Women's Cohort (UKLWC),ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,e0b951ba-0f7d-4743-9374-b965042accdd
33.33,cbab40e4-9e61-4466-b706-db47771d2512,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Congenital Anomaly Register and Information Service (CARIS),,Not Rated,19.05,6fe7e004-eb51-4c7b-9905-1ec9a4827dca
33.33,cbb0568c-510e-49de-af43-edb9345535a8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Falls & Fragility Fracture Audit  Fracture Liaison Service  clinical dataset,,Not Rated,19.05,d94a604c-5733-4f07-93bb-e77b6ea2313f
33.33,cc1a15ea-1bca-42c5-9915-8e6bfd733d6e,55.81,36.5,Not Rated,1.1.7,60.32,31.62,SARS-CoV-2 viral sequencing data (COG-UK data) - Lineage/Variant Data - Scotland,,Not Rated,19.05,69a356d6-599e-4d02-8241-066ce3c297bd
77.78,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4.1 (Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0
63.49,cde234d0-748b-4df6-a59d-3268cc7e8c1d,20.93,72.22,Silver,1.1.7,19.05,76.44,RIO,ALLIANCE > TISSUE DIRECTORY,Bronze,73.81,18bc81e3-7d99-4152-bd7a-3c90ee7e489d
98.41,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,16.28,88.89,Gold,1.1.7,20.63,88.29,Postponed Admitted Procedures,ALLIANCE > SAIL,Gold,92.86,bff94600-a254-4111-82f7-6167084d81ca
15.87,ce1bcddb-a6af-4511-84c6-2a252d3eb202,39.53,38.88,Not Rated,1.1.7,38.1,39.76,Maternity Services Dataset,ALLIANCE > BARTS HEALTH,Not Rated,19.05,173d07ab-5930-4d19-b3de-dcca193e62fd
96.83,ce896b89-5f4a-407c-bb10-7eec51089458,20.93,84.92,Silver,1.1.7,26.98,85.97,North West London Community Data (NWL COM),HUB > DISCOVER NOW,Silver,92.86,65dad445-ed81-4005-9f5a-4f8a7164043e
100.0,cea328df-abe5-48fb-8bcb-c0a5b6377446,13.95,92.06,Gold,1.1.7,15.87,90.64,Welsh Demographic Service (WDS),ALLIANCE > SAIL,Gold,95.24,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d
92.06,cf1feb84-837e-4f51-8320-6171f4970a5f,27.91,80.95,Silver,1.1.7,30.16,78.9,Death Registration data for CPRD GOLD,ALLIANCE > CPRD,Silver,85.71,1d35e229-13eb-4be1-9dae-4752b6c27c4a
60.32,cf64602c-7703-4f29-bd90-e0d511e2b24e,16.28,71.43,Silver,1.1.7,17.46,77.58,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,HUB > BREATHE,Bronze,71.43,490747bf-b268-41f3-8f35-f6bc4a4bdbfa
33.33,cf867e7f-51b9-4627-828d-dd4fd420b37e,55.81,36.5,Not Rated,1.1.7,60.32,31.62,The Airwave Health Monitoring Study,,Not Rated,19.05,98bfe17f-be12-47b1-943a-2d3a621b7618
98.41,cfdb9fbd-9f67-435c-b257-6b51430451bb,16.28,88.89,Gold,1.1.7,20.63,88.29,Referral to Treatment Times,ALLIANCE > SAIL,Gold,92.86,0bf54842-c1db-4bdb-9f55-c5be490bf758
33.33,cfea1343-daea-43cf-b73c-c4eebecee182,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Labour Force Survey (Household),,Not Rated,19.05,0b630200-1e7c-4b19-ad53-bcc8863f7ade
60.32,d006821e-a507-4699-b560-b5d023e09d4b,16.28,72.22,Silver,1.1.7,15.87,76.38,Cancer Group CTR Cardiff trials,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,cd833805-f0a8-4ddb-a50d-b12695c92120
33.33,d07f2709-ccc7-410b-9b73-a45918e21fed,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Child Health Systems Programme - 6-8week review,,Not Rated,19.05,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04
33.33,d094b10a-b1b4-4805-9424-33547e9c46ba,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry Audit - Carotid Endarterectomy Clinical Dataset,,Not Rated,19.05,f857055b-c29e-4c7f-99ce-65f4ed59648e
90.48,d0f5761c-66af-4a1c-81c3-eae0f87724b1,27.91,80.16,Silver,1.1.7,30.16,77.71,Death Registration data for CPRD Aurum,ALLIANCE > CPRD,Silver,83.33,ad8f07ef-a984-449b-8a60-d1dd564cc36d
23.81,d15b6d4a-a5de-4df4-8f29-4a8926af8024,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,ALLIANCE > HQIP,Not Rated,28.57,a464c126-8591-4af6-a10f-99c020f59527
98.41,d27f265d-8931-4f76-83a2-cb47189a53f0,16.28,90.47,Gold,1.1.7,17.46,88.29,Welsh Dispensing Dataset,ALLIANCE > SAIL,Gold,92.86,50ef6443-ed4b-40f9-97fb-1cfd53be6579
33.33,d2981964-3ff7-47e2-91e1-ac5812227a80,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR IBD BioResource: Case report form,,Not Rated,19.05,877a7275-b99d-4ed4-9691-de577e0ab49e
46.03,d2af6a29-291b-4444-a17c-40f4208f1e1b,51.16,46.03,Not Rated,1.1.7,53.97,41.09,Patient Reported Outcome Measures,ALLIANCE > NHS DIGITAL,Not Rated,33.33,55614ed3-2484-4408-a4e9-e5fffed9e8e4
100.0,d2da2750-7482-4ce9-ae5c-2ab393408a67,18.6,87.3,Gold,1.1.7,25.4,88.32,Education - Wales,ALLIANCE > SAIL,Gold,95.24,204fa806-071d-4410-9c2c-143017d32d24
33.33,d3010e1b-09ea-49e5-a5fb-3cf5a030fda6,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Cancer Network Information System - CNIS / CANISC,,Not Rated,19.05,da91f0eb-1761-485b-8b7f-9121b6a1d004
14.29,d3fd4dac-2d15-401c-8185-905ee108d9ce,37.21,38.89,Not Rated,1.1.7,36.51,39.73,JANUS,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,6590f79d-cfea-4695-9fe0-dc5f85e6d273
33.33,d42aa93a-ecc3-480b-a55b-d089dbc11413,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Annual District Birth Extract (ADBE),,Not Rated,19.05,12a77014-4a77-4eb1-8b26-f49689352d1b
33.33,d4683e8d-9c3f-4e5e-874c-80333a1ef719,51.16,41.27,Not Rated,1.1.7,50.79,33.95,National Neonatal Audit Programme - clinical audit,,Not Rated,19.05,49b67625-4c9a-4101-a982-e733e7db20ca
33.33,d524cd6b-14be-44a5-868c-f3e187d4e5d8,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Follow-COVID,,Not Rated,19.05,e50d2b20-ef95-43fe-bbf0-83224d88e480
14.29,d57a096a-4fa3-4529-b508-0b9df0f1893c,37.21,38.89,Not Rated,1.1.7,36.51,39.73,OUH Patient Master Index,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,5d7465f6-ced8-434b-9907-d357ad125024
42.86,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,23.26,60.32,Not Rated,1.1.7,22.22,62.18,INTERVAL,OTHER > The University of Cambridge,Not Rated,47.62,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b
4.76,d5af13e0-cbcc-47f9-8d85-21867f198051,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Use of digital auscultation to improve diagnosis of paediatric pneumonia,,Not Rated,4.76,198bd2cc-ca40-4dff-992c-a9480703fc37
61.9,d614f4fc-fae9-4775-86d9-4d4710017cf4,30.23,63.49,Not Rated,1.1.7,34.92,61.08,TRACK-COVID,OTHER > UNIVERSITY OF CAMBRIDGE,Not Rated,52.38,9e89af6b-bfa8-43dc-a2d4-5540c899a670
60.32,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,18.6,71.43,Bronze,1.1.7,17.46,75.22,UNIRAD UK Sample collection,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,a1d16f3f-c7e7-41c5-a071-07889bf49ab1
33.33,d6d1588d-b65c-479d-8f15-7fddf5ed4cc0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NACAP Pulmonary rehabilitation - clinical audit,,Not Rated,19.05,3afbb83d-d47b-43b3-a202-0d3081e5d294
4.76,d7f1b4ab-ae3c-4318-afc9-1b561d46d442,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Research on use of an online learning platform on under-five pneumonia,,Not Rated,4.76,a3d85fd2-9df3-4f6e-9035-0830a3488ddb
33.33,d864c698-b98c-4a1e-9c6a-7b941d61a35c,55.81,36.5,Not Rated,1.1.7,60.32,31.62,BathTAP Headache Cohort 1,,Not Rated,19.05,9cff3fc9-25d6-49fe-8218-dbbc3b3bc1ab
33.33,d89732fc-1bc3-4bd6-a634-9e9d03f3fea4,53.49,38.88,Not Rated,1.1.7,55.56,32.78,HIV PiNS,,Not Rated,19.05,1abc859e-4ac6-431a-b550-af1afb36df1b
4.76,d95be3ed-f767-4ea5-9e4d-295446f68eb5,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Generation Scotland: Scottish Family Health Study,,Not Rated,4.76,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d
33.33,d977abd8-a966-4b4c-99f0-7a4c368f9934,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Regsitry - Oragnisational Audit dataset,,Not Rated,19.05,3c661240-e4d2-456c-a809-133c23f9c469
33.33,d9fc7ff7-6de4-4757-a2e3-d49f222ea1dd,55.81,36.5,Not Rated,1.1.7,60.32,31.62,CDE Documentation,,Not Rated,19.05,f866b225-10b8-4df4-9c32-072411f816d8
33.33,da139725-1b1e-4ccd-83ab-2951d2fedca5,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Deeply phenotyped clinical data for hospitalised Atrial Fibrillation patients,,Not Rated,19.05,572b3ccd-4213-4a41-9255-3096952a2954
4.76,da191840-9037-4e1f-8e6c-ec66eb80b798,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Child Health Systems Programme - School,,Not Rated,4.76,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4
100.0,da5098df-414f-48e0-aaa7-7e2277f80eb7,13.95,92.06,Gold,1.1.7,15.87,90.64,Looked After Children Wales,ALLIANCE > SAIL,Gold,95.24,cfdafacb-48f0-4ad8-9f20-193a5eec2da4
60.32,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,16.28,72.22,Silver,1.1.7,15.87,76.38,King's Health Partners Cancer Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,a218d0b4-0273-4a04-ba17-c01dae6dcf33
77.78,db113fcd-69a0-4357-9c6d-250085deb3f5,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4.1 (Sensitive) Events,ALLIANCE > NHS DIGITAL,Not Rated,64.29,a1154967-a80e-41da-a9ae-6183584ecf6b
33.33,db53c086-db48-4f7e-9264-ed44a9154753,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry Audit  - Lower Limb Amputation clinical dataset,,Not Rated,19.05,03e77b9d-57b8-44d5-8d64-9b1325958b22
71.43,db89a123-0402-4962-8a8f-78557ba4d84f,9.3,80.16,Silver,1.1.7,11.11,85.83,UK Lung Volume Reduction Surgery,HUB > BREATHE,Silver,80.95,9f98a674-12f6-42f4-b1a5-322b3b75eef1
17.46,dba474a3-90c4-423d-beb0-5ef79c490d24,37.21,40.48,Not Rated,1.1.7,36.51,42.11,"NHS Tayside, A&E Drugs given during an A&E visit",HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,Not Rated,21.43,acfbef89-344c-49a5-8079-7344f4316e0f
4.76,dbcf49c1-f23c-4bb8-8c4f-6fc4e996ff97,46.51,29.36,Not Rated,1.1.7,46.03,29.12,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,,Not Rated,4.76,51d41006-727e-43d4-bdb6-f8b427c295c6
33.33,dc5507d0-807e-4981-906b-731690a5e085,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Outpatient Dataset (OPDW),,Not Rated,19.05,d331159b-b286-4ab9-8b36-db39123ec229
63.49,dcb4c87b-5884-41c0-b9af-d7d094dd0922,16.28,73.81,Silver,1.1.7,15.87,77.58,NHS Greater Glasgow & Clyde Bio-Repository,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,762976cc-83d0-4b31-a879-37f87f947406
33.33,dcd6f957-1fcc-481a-bbd2-89abfe933449,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Prescribing,,Not Rated,19.05,6d044471-62d2-4190-b315-503f77d33ef2
4.76,dd6e4344-9cee-41f3-8062-6bb9cdfda012,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Decode-ME,,Not Rated,4.76,a71d0b2a-620c-4c04-b7bb-45843461db9f
60.32,ddbc149a-db56-41de-bd2c-3624149f6e7e,16.28,72.22,Silver,1.1.7,15.87,76.38,MesobanK,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,b03835b7-7408-49a0-a9aa-ea405f9855c9
60.32,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,16.28,72.22,Silver,1.1.7,15.87,76.38,NIMRAD-TRANS,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,039b55f7-d416-49ab-9bdb-4ff7dbc733df
4.76,ddf35f0d-ca89-4f74-bbdd-65d1a84b38ca,46.51,29.36,Not Rated,1.1.7,46.03,29.12,VIKING GENES,,Not Rated,4.76,43636f80-27fd-43d0-8556-d0a2de0cd819
65.08,de4b46f5-1591-442d-a896-6e0d91657c01,13.95,75.4,Silver,1.1.7,14.29,79.93,Children's Health in London and Luton (CHILL),HUB > BREATHE,Bronze,73.81,722be723-04bd-48b4-923b-e7d393f0c22b
33.33,de8d0b95-b968-45f2-8cd4-2c87d72ff729,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK Renal Registry - COVID-19 dataset,,Not Rated,19.05,2a3dba77-34ff-4781-b273-1b3d54d11f32
100.0,df23aabd-3e5f-4fc2-aad6-af990cff6f19,23.26,86.51,Silver,1.1.7,26.98,85.99,Children’s Kidney Cancers - Great Ormond Street Hospital,HUB > DATA-CAN,Gold,95.24,3f71bef5-c5a2-400c-a482-2ad30b29a240
95.24,df3cc57d-08ae-4e81-ae79-283d71cf8d95,23.26,83.34,Silver,1.1.7,28.57,83.61,IBD NIHR BioResource: SNP chip data,HUB > GUT REACTION,Silver,90.48,3c749cfc-4008-4916-b64f-969d6a754c0f
33.33,df55c56f-b081-45f4-b265-ed1b2c6d94cd,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Welsh Health Survey Dataset (WHSD),,Not Rated,19.05,e4d8edb3-6e8e-435d-9732-60c83027d8f9
57.14,dfba178f-ce67-4c2d-8693-b23110aeecae,25.58,66.66,Bronze,1.1.7,23.81,68.16,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),ALLIANCE > HQIP,Bronze,61.9,e355c9b9-44f0-4ba3-a872-645aa88f4f2b
33.33,dfc16033-7620-4002-aa3b-e5bbc400bbfd,53.49,38.88,Not Rated,1.1.7,55.56,32.78,MATCH,,Not Rated,19.05,5429fc2a-3d72-414d-9393-4079c4c6c0fa
60.32,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,16.28,72.22,Silver,1.1.7,15.87,76.38,Generation Scotland,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,019fad36-65ea-4d47-8d6d-a47240eeb801
33.33,dfd65358-d5a4-40f1-873a-c8c304799cbf,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NIHR BioResource: Demographic,,Not Rated,19.05,d2c486bb-b95b-4093-bb58-b196cfc08c7b
23.81,dfedefac-c389-4d07-a8a3-eb2e4ff34587,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),ALLIANCE > HQIP,Not Rated,28.57,3efd9b30-1f84-48c0-a3e0-402ecb5c7724
4.76,e00284e3-439b-4a6d-9781-679c539404f8,46.51,29.36,Not Rated,1.1.7,46.03,29.12,COVID Tests,,Not Rated,4.76,607b17d6-74de-466a-a377-238444707abb
33.33,e05de62a-91be-46b8-8c1d-c9ed89d8c740,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Laboratory turnaround times processing electronic blood test orders in the NHS,,Not Rated,19.05,971e2827-3aa4-4af3-bdce-3c8419897654
33.33,e096053e-b028-4487-a6d0-6958cbb5f388,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UK Renal Registry - Your Health Survey dataset,,Not Rated,19.05,14ed4ab3-470b-45c8-b48f-27fd382a912e
85.71,e149e0c4-7edd-4e9c-af9d-2b3b2baef9bd,30.23,78.57,Bronze,1.1.7,28.57,72.98,Rural-Urban classification for CPRD Aurum,ALLIANCE > CPRD,Silver,76.19,b7d24b82-f8a4-4838-844c-ecd86ddf5db2
69.84,e172870f-37c4-4103-afae-8a60cae43ccb,9.3,79.37,Silver,1.1.7,11.11,84.63,SpiroMeta Consortium Dataset,HUB > BREATHE,Silver,78.57,fb6d98c5-e41d-4804-bb28-839556e0f657
85.71,e22f93fb-bc08-44eb-b292-dc2baf0ad343,25.58,80.16,Silver,1.1.7,25.4,76.5,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,HUB > PIONEER,Silver,78.57,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb
60.32,e3373d01-48c6-49bc-8c9b-827831e525b3,18.6,71.43,Bronze,1.1.7,17.46,75.22,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,f94168a1-cab8-4211-90e0-38a241609697
33.33,e38ceae6-1ef7-4a26-90c9-9b0c920b3df7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,The impact of multimorbidity on care pathways during COPD hospitalisations,,Not Rated,19.05,76167567-9221-4024-bccf-dfdfb9e4bb07
63.49,e443bc67-bc8a-430b-88a9-d3380cd2ae38,16.28,73.81,Silver,1.1.7,15.87,77.58,eLIXIR - Early Life Data Cross-Linkage in Research,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,c8cd0645-b728-4c62-84b8-036c1d8763be
4.76,e4a1be81-8f3c-4731-ae8a-7cbd594c78f5,46.51,29.36,Not Rated,1.1.7,46.03,29.12,IBD Registry,,Not Rated,4.76,a406d06b-350e-4392-ab4e-b1012e422a34
33.33,e4a745d6-f44c-481a-b337-aae4cfe72594,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Care Home Dataset (CARE),,Not Rated,19.05,aae02f9e-1bad-415d-9730-c46a07a990aa
33.33,e5a0c70c-7429-487d-8dc7-04cf073191cc,58.14,34.12,Not Rated,1.1.7,65.08,30.45,NHS Scotland General Practice (GP) Contact Data - Subset,,Not Rated,19.05,8f486c3d-9504-4a0e-8e24-ab96f057fc9e
23.81,e6433c92-8439-4e2e-a3e7-016e7812dcfb,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6
33.33,e6d31775-961b-457f-886c-1c0672308a55,55.81,36.5,Not Rated,1.1.7,60.32,31.62,HDR UK Papers & Preprints,,Not Rated,19.05,fd8d0743-344a-4758-bb97-f8ad84a37357
4.76,e70f4e13-440b-4dec-a13c-c17d9d9da553,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Emergency Laparotomy Audit - Patient Audit Dataset,,Not Rated,4.76,25b93812-191f-49bb-bbd0-782fb85b2bd2
63.49,e7979d81-708d-4657-857c-4ca95d05cda2,16.28,73.81,Silver,1.1.7,15.87,77.58,IDRIS Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,8437b207-c925-4dd1-9478-5af329cd736e
69.84,e79c5f26-deb0-4531-834d-58912c9fe663,25.58,69.84,Bronze,1.1.7,30.16,68.16,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),ALLIANCE > GREAT ORMOND STREET HOSPITAL,Bronze,61.9,435bfcda-f378-44f6-9387-042d959eb945
33.33,e7b615a0-2867-47ff-bb40-0d459b41226c,55.81,36.5,Not Rated,1.1.7,60.32,31.62,BathTAP Headache Cohort 2,,Not Rated,19.05,2d79feab-3046-4735-a4ec-a4c11c9c1aa8
33.33,e8932b23-ed21-40f4-8fb1-00ef186e6ee1,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Air Pollution Exposure Estimates,,Not Rated,19.05,584cbecc-43ef-4015-adf7-ff70178d7abe
53.97,e8c3b66d-f06b-4e3f-944d-f65235133f00,20.93,66.67,Bronze,1.1.7,20.63,70.48,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,HUB > BREATHE,Bronze,61.9,e8afaf39-86fa-4085-a075-6118cc25fae0
33.33,e956a7a4-896b-47dc-8d98-f48385d110f7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Brecon Dataset (BREC),,Not Rated,19.05,9c6e891f-6449-48d2-a1c3-8dd236e34bbd
33.33,e9820518-54e3-46d1-a63f-c5da867dcd82,53.49,38.88,Not Rated,1.1.7,55.56,32.78,IBD NIHR BioResource: Health and Lifestyle Questionnaire,,Not Rated,19.05,18bfe765-5733-41f3-8114-0a1ec2524b5b
33.33,e9902b10-84ca-495f-a4d9-a9948d0d64ca,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Asthma and COPD Audit Programme - Pulmonary rehab organisational audit,,Not Rated,19.05,4b33fc6d-3cac-4404-adac-d693328456fa
33.33,e9cdc12c-6938-4c18-b45c-e0a77df6de56,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Hospitalised Community Acquired Pneumonia before & during the COVID-19 pandemic,,Not Rated,19.05,1861b3dd-4969-490e-9faf-c57809f56bc1
100.0,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,16.28,89.69,Gold,1.1.7,20.63,89.48,Children Receiving Care and Support Census,ALLIANCE > SAIL,Gold,95.24,fb3fac03-a428-4b3f-8058-5622e1fd57d8
14.29,eaca9ed1-30b6-4157-8894-8e53efc84849,37.21,38.89,Not Rated,1.1.7,36.51,39.73,Sunquest,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,a80b2567-4755-46f1-bd2a-f3817ce4f10c
33.33,eaec06fa-a27e-46d1-9be9-6e1f9a16fb5d,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Scottish Birth Record (SBR),,Not Rated,19.05,81c53293-ef64-4507-8fcf-2a254dc19936
4.76,eb030592-7f5d-4969-abde-c4a962251406,46.51,29.36,Not Rated,1.1.7,46.03,29.12,English Longitudinal Study of Ageing (ELSA),,Not Rated,4.76,f12cb023-1402-49d1-aa27-e0fe4ed19fd7
4.76,eb376dc5-1abb-4d06-a39a-e479078bcf9d,46.51,29.36,Not Rated,1.1.7,46.03,29.12,ICT-based intervention for adult asthma with limited health literacy,,Not Rated,4.76,1d6b02f1-47b8-42ad-919d-f738b545cff7
100.0,eba50bb1-e971-4062-8ece-81be39ceca5b,16.28,89.69,Gold,1.1.7,20.63,89.48,Annual District Death Extract,ALLIANCE > SAIL,Gold,95.24,15cf4241-abad-4dcc-95b0-8cd7c02be999
33.33,ec121652-b3ab-4f90-8b93-ab5f6b1bc64c,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Community Services Data Set,,Not Rated,19.05,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70
63.49,ece82228-9af1-4699-a763-b4608908b645,16.28,73.81,Silver,1.1.7,15.87,77.58,NHS Grampian Biorepository,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,10d0def8-dc03-473f-b60b-4c0dc3642a25
23.81,ee099373-8a72-4ec7-818f-3cbb9c8a793d,34.88,44.45,Not Rated,1.1.7,34.92,46.84,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,ALLIANCE > HQIP,Not Rated,28.57,025c9e8a-938b-4886-9e03-fcad90fe7157
33.33,ee2350f2-c619-446e-9785-fce8e0ac9f44,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Hospital Episode Statistics Accident and Emergency,,Not Rated,19.05,3ddfccc3-ba32-4653-a999-966b8d6c412f
60.32,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,18.6,70.64,Bronze,1.1.7,19.05,75.22,The PEACE Study,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,33b1a989-5f61-412e-bdae-b551c92d1ed6
33.33,eee15509-f23a-441e-b5be-ee76bd2ba649,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Scottish Covid-19 Vaccination Data,,Not Rated,19.05,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2
4.76,ef478925-7612-4cd6-a10e-5e64ee8a0f4d,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Understanding Society,,Not Rated,4.76,932cecdf-65fb-4e3d-9454-7a2d0585e970
15.87,ef727724-6c38-483b-b28d-8e94b5a9d7ac,39.53,38.88,Not Rated,1.1.7,38.1,39.76,Freetext Dataset,ALLIANCE > BARTS HEALTH,Not Rated,19.05,0f07f939-1265-4e8b-aaa6-d897d254c2f3
33.33,f0109da2-6452-45a9-928e-5376dcb78609,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Coronavirus and the Social Impacts on Great Britain,,Not Rated,19.05,e253257c-48c2-491b-b3b9-205161a16a7e
33.33,f08bfb75-f2b8-4afb-9c3d-59cdd2b6b3ce,51.16,41.27,Not Rated,1.1.7,50.79,33.95,GP Out of Hours,,Not Rated,19.05,731dc868-3e79-4722-9b79-6bb8dec9435b
90.48,f0fc13b4-f801-4647-82f3-07ed07f26ea0,25.58,80.96,Silver,1.1.7,28.57,78.88,Welsh Health Survey Dataset,ALLIANCE > SAIL,Silver,83.33,e4d8edb3-6e8e-435d-9732-60c83027d8f9
33.33,f16f0b1b-650d-486b-bc89-946b1623103e,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Child Health Systems Programme - 13-15 Month Review,,Not Rated,19.05,e77af7a3-32fa-4a08-8455-4fb489e5b64a
87.3,f2268d4e-0149-4913-9832-0399960eecd4,25.58,77.78,Silver,1.1.7,31.75,77.69,North West London Acute Patient level Data (NWL Acute PLD),HUB > DISCOVER NOW,Silver,80.95,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6
15.87,f2b4211b-1af7-46ff-82a3-35b29d1d478e,39.53,38.88,Not Rated,1.1.7,38.1,39.76,"Problems, Diagnosis and Procedures",ALLIANCE > BARTS HEALTH,Not Rated,19.05,51b41359-1558-48df-9950-88f75ca6ac4c
33.33,f2c2ea2f-f5e8-4297-8510-c2d430ff0946,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Emergency Department Dataset (EDDS),,Not Rated,19.05,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c
33.33,f3957e36-25eb-4e0a-a69a-a1c0ce85cb4f,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Identification of Medical Admissions suitable for Same Day Emergency Care (SDEC),,Not Rated,19.05,7af96f17-5ab6-4275-b8ef-61a3e053d342
33.33,f3f24eff-a21b-45e4-92a2-71c162426f53,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Capture-24: Activity tracker dataset for human activity recognition,,Not Rated,19.05,5713fd1a-4358-4485-bed5-83fb25ec2fce
33.33,f58a3c47-44aa-4815-aeab-e19a4a330926,53.49,38.88,Not Rated,1.1.7,55.56,32.78,UHB Linked Diabetic Eye Disease and Cardiac Outcomes,,Not Rated,19.05,4385ed4c-1c42-4ba5-b57f-9ab18e5ffbe1
33.33,f5d0e254-1005-43a9-88d3-5180c015b7f0,51.16,41.27,Not Rated,1.1.7,50.79,33.95,CAFCASS Wales (CAFW),,Not Rated,19.05,29a714e1-5289-4362-be24-2848c954344e
33.33,f635894a-61b8-40ad-bfa2-4c31ef23ad34,53.49,38.88,Not Rated,1.1.7,55.56,32.78,Epilepsy 12 - National organisational audit and Trust profile,,Not Rated,19.05,2c737d63-69f4-4a02-8df9-54c1e65e845f
4.76,f636abcd-91b1-4408-b44b-5f6274bc98d6,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Cardiac Audit Programme - Myocardial Ischaemia National Audit (MINAP),,Not Rated,4.76,3558f8a1-6d52-4b59-b513-51c068095bc2
100.0,f6aa8836-b437-40b6-bd1e-ae20010048dd,16.28,89.69,Gold,1.1.7,20.63,89.48,Substance Misuse Dataset,ALLIANCE > SAIL,Gold,95.24,291c0dd4-0988-42d2-8e0b-878a892add57
96.83,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,20.93,86.51,Silver,1.1.7,23.81,85.97,North West London Integrated Care Record (NWL ICR),HUB > DISCOVER NOW,Gold,92.86,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c
63.49,f71e0f89-edf6-4070-9045-6024b00f79ca,16.28,73.81,Silver,1.1.7,15.87,77.58,PHOTO Translational bladder cancer biorepository,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,07d1b768-78f6-41e8-995a-66afd2549b34
33.33,f76d0428-f93c-41ba-9ebb-08e4211bf17a,55.81,36.5,Not Rated,1.1.7,60.32,31.62,Suspected Cancer Pathway Monthly (SCPM),,Not Rated,19.05,fcf5a844-f48d-428e-aa06-abe64e66185e
82.54,f80940e8-0ee1-46be-876b-46fb4bbbc4d2,25.58,78.57,Bronze,1.1.7,25.4,75.31,Medicines dispensed in Primary Care (NHSBSA data),ALLIANCE > NHS DIGITAL,Silver,76.19,f201b68f-d995-4a70-a9ee-aa3510232777
84.13,f8a268c1-831c-4c80-b62c-e254a572b9a0,25.58,79.36,Bronze,1.1.7,25.4,75.31,Ventilation strategies for patients on intensive care,HUB > PIONEER,Silver,76.19,1a66dbc1-4f06-455c-85fc-68b372575cad
17.46,f93aea28-7592-42c0-a5e7-5802f0d6051f,34.88,41.27,Not Rated,1.1.7,34.92,42.09,UK Longitudinal Linkage Collaboration (UK LLC),OTHER > UK Longitudinal Linkage Collaboration (UK LLC),Not Rated,19.05,d858cd90-9a2f-4330-9bbe-46e047a5d0a2
33.33,f969e45f-3a71-4dc0-b5ef-476963fe86d5,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Daily Situation Report Data (DSRD),,Not Rated,19.05,c74a9b9e-1fea-4aac-99fd-54e30668e085
33.33,f98d83ec-ad27-46d7-9786-7a0f2749aa11,51.16,41.27,Not Rated,1.1.7,50.79,33.95,2019 UK Parkinson's Audit - Speech and language therapy,,Not Rated,19.05,c7f7541b-5030-40b9-962a-4aba44af7e1a
33.33,f98f9578-a4a3-4d93-b32e-f30ff75888b7,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Bowel Screening Wales (SBSW),,Not Rated,19.05,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef
36.51,f9959c00-c063-4fbf-933d-755e3b6ecedc,23.26,57.14,Not Rated,1.1.7,22.22,58.61,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,ALLIANCE > IMPERIAL COLLEGE LONDON,Not Rated,40.48,70656016-c1c9-4bc2-93d1-c66341fcdf36
63.49,f99d82da-13eb-42db-ad0d-348be2173535,16.28,73.81,Silver,1.1.7,15.87,77.58,Tommy's National Reproductive Health Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,20639743-9a28-43dd-a8af-7571ece2a7f8
63.49,f9c40294-92d8-45cd-b11a-70eb0fc09004,18.6,73.02,Silver,1.1.7,17.46,76.42,PHOENIX DDR-Anti-PD-L1 Trial,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,df94730b-374b-4d91-8116-1c10a7c77c4e
33.33,fa07a8df-4584-4dc1-87f9-f03ff8d31861,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,,Not Rated,19.05,d357be1e-27fe-4b2f-9174-3a2a03ecc12b
25.4,fa179e24-2068-4c34-b73c-230003010e9f,34.88,45.24,Not Rated,1.1.7,34.92,48.04,Genvasc Primary Care Data,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,Not Rated,30.95,f397acff-a7af-4062-8e8b-c85889cc41df
33.33,fa45c071-1852-4c02-bddc-fda4517bffa8,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Scottish Cancer Registry (SMR06),,Not Rated,19.05,ad36dc03-1856-44de-99b0-1af6f312d86b
38.1,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,27.91,56.35,Not Rated,1.1.7,25.4,57.48,Hospital Inpatient data,UK Biobank,Not Rated,42.86,97c68424-dc80-4faa-b777-67c42f92a9b6
100.0,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,13.95,92.06,Gold,1.1.7,15.87,90.64,Breast Test Wales,ALLIANCE > SAIL,Gold,95.24,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b
71.43,fb50af29-4aa6-4071-9300-bd2d57c850b0,9.3,80.16,Silver,1.1.7,11.11,85.83,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,HUB > BREATHE,Silver,80.95,b850e56c-5c5b-413e-b829-743772053978
33.33,fb65ff7c-fc02-402e-ab55-59765d7b0d43,53.49,38.88,Not Rated,1.1.7,55.56,32.78,NHS Tayside and Fife Immunology,,Not Rated,19.05,39055449-c074-4b58-adb2-b1c0d2441c4d
4.76,fba3b66d-8d3a-473f-bb3d-537a6ab1fa7a,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Asymptomatic COVID-19 in Education (ACE) Cohort,,Not Rated,4.76,48adf432-9b66-4d03-a25e-008fbbb24f56
23.81,fbb5d74c-802a-4888-9452-3e0faf257f82,34.88,44.45,Not Rated,1.1.7,34.92,46.84,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),ALLIANCE > HQIP,Not Rated,28.57,33b36393-3760-40d8-bb98-61806fea5398
23.81,fc08ad6a-3e94-44db-a122-945c4c875616,32.56,45.24,Not Rated,1.1.7,33.33,48.0,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,ALLIANCE > HQIP,Not Rated,28.57,f857055b-c29e-4c7f-99ce-65f4ed59648e
96.83,fc704af0-368b-4dd0-866f-753b6d1dccf8,18.6,85.72,Gold,1.1.7,25.4,87.13,North West London High Cost Drugs Data (NWL HCD),HUB > DISCOVER NOW,Silver,92.86,75638d2c-556a-46b6-afcc-7ab425b34679
14.29,fc7b44f0-eb69-4257-8c07-7516c1210c46,37.21,38.89,Not Rated,1.1.7,36.51,39.73,CellPath,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,Not Rated,16.67,c4538af4-505f-45df-aeae-788ddfd7cb54
4.76,fc7ea07b-d60f-4be9-a840-89b17d4c2414,46.51,29.36,Not Rated,1.1.7,46.03,29.12,National Bowel Cancer Audit - clinical dataset,,Not Rated,4.76,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111
60.32,fd2317ea-c729-433b-b578-309118118b78,16.28,72.22,Silver,1.1.7,15.87,76.38,Infectious Diseases BioBank at King's College London,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,47b544f4-301c-43e0-b347-fc623ea1a8b3
87.3,fd296ed6-6e12-49ab-9e5f-f40428a47b02,27.91,79.37,Silver,1.1.7,28.57,76.52,MSDS (Maternity Services Data Set),ALLIANCE > NHS DIGITAL,Silver,80.95,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc
36.51,fdb053d7-375a-4422-aa16-c899661d72b1,25.58,54.77,Not Rated,1.1.7,26.98,59.83,"Projections of global, regional and national prevalence of asthma from 2018-2040",HUB > BREATHE,Not Rated,45.24,0911f991-6c0f-4412-b805-1ee0ded93a12
33.33,fe168c6f-7533-413e-94fd-066fd845d7c0,53.49,38.88,Not Rated,1.1.7,55.56,32.78,National Joint Registry - Revision Knee Replacement dataset,,Not Rated,19.05,6664317b-39b9-4133-b6c7-ec4bddf78c76
60.32,fe3f2246-aec4-4be4-8f51-3e5bde80931d,16.28,72.22,Silver,1.1.7,15.87,76.38,Bristol Biobank,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,9d56ae46-5955-4f03-a93c-a4a6d9f641ab
33.33,fe8852b2-9d0b-4145-8f5c-531378731d39,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Healthcare Workers Risk Assessment (HWRA),,Not Rated,19.05,ed131fee-0635-4613-a453-a383d5dd7cec
33.33,feb9a877-2e22-4a5b-a260-5c5186224028,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Emergency hospital admissions in patients from care home settings,,Not Rated,19.05,6009f720-3cd5-449d-b36b-e2ccf3fbc73a
23.81,fed22efe-8a84-4b1e-a642-2412a1420ce8,34.88,44.45,Not Rated,1.1.7,34.92,46.84,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,ALLIANCE > HQIP,Not Rated,28.57,e06b951b-e9d8-4a2c-a51f-1d819f669205
60.32,fede80e2-aea9-4229-8024-39b09110be7b,16.28,72.22,Silver,1.1.7,15.87,76.38,REQUITE,ALLIANCE > TISSUE DIRECTORY,Bronze,69.05,b5217dcb-582f-4914-ae45-9eb3899add30
33.33,fee7f039-99d6-4eab-951d-b35e0ae71a75,55.81,36.5,Not Rated,1.1.7,60.32,31.62,UK SARS-CoV-2 viral sequencing data (COG-UK data)-Lineage/Variant Data-Scotland,,Not Rated,19.05,69a356d6-599e-4d02-8241-066ce3c297bd
33.33,ff0750c4-2765-4bf6-a294-33215f1ced77,51.16,41.27,Not Rated,1.1.7,50.79,33.95,The impact of COVID on hospitalised patients with COPD and hospital services,,Not Rated,19.05,a1c4dda9-d34b-443f-aaaf-231f2e0c31fa
4.76,ff0ee5d5-aeb4-4dc0-bddf-79336e0ab004,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Enhancing access to pulmonary rehabilitation through implementation research,,Not Rated,4.76,6265a41f-9444-457b-b401-1d0978f5c58a
33.33,ff10d5c4-42a2-4a06-b6af-a2f7393c62e0,51.16,41.27,Not Rated,1.1.7,50.79,33.95,Mortality (Death registration),,Not Rated,19.05,59fb436a-f8c3-4d4a-bc76-d4a02904b078
77.78,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,44.19,64.28,Not Rated,1.1.7,49.21,60.05,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,ALLIANCE > NHS DIGITAL,Not Rated,64.29,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4
4.76,ff727b8e-4805-424a-ba34-acc9b90225fe,46.51,29.36,Not Rated,1.1.7,46.03,29.12,Oxford Carpal Tunnel Syndrome (CTS) Cohort,,Not Rated,4.76,cd3555b0-514a-4693-8f68-c8267a8e9939
63.49,ff8231e5-3ede-4844-a21b-b1d05120e07e,16.28,73.81,Silver,1.1.7,15.87,77.58,IMPORT HIGH trial blood samples,ALLIANCE > TISSUE DIRECTORY,Bronze,71.43,edafebac-9479-4d2c-b44e-349091d5b35b
